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Nitroindoles, despite their scanty occurrence in nature, are attractive reactive 
intermediates in organic synthesis thanks to the coupling of the properties of the nitro group 
and of the indole moiety.[1] While nitration of the pyrrole nucleus can be easily achieved, 
nitration on the benzene ring represents a more challenging target. Ex-novo construction of the 
pyrrole onto a functionalized benzene derivative is, by far, the synthetic strategy most 
frequently exploited to access indole nitrated on the benzene ring. Herein, we expand the 
synthetic access to such nitroindoles reporting an original protocol based on the ex-novo 
construction of the benzene ring onto pyrrole employing mono- or dinitro-1,3-butadienes as 
powerful C4 benzannulating agents. This appealing, metal-free process characterized by high 
atom economy and mild reaction conditions allows to synthesize nitroindoles characterized by 
patterns of substitution not easy to be obtained otherwise.[2] Such unusual substitution patterns 
have demonstrated to be promising for further elaborations, i.e. the application of the classic 
Cadogan reaction conditions in order to access pyrrolocarbazoles with a rarely reported ring 
fusion.[3]  
A very interesting side project regarded the synthesis of a series of atropisomeric naphthyl 
nitroindoles with two stereogenic axes originated from steric hindrances forcing the naphthyl 
groups out of the indole plane; the asymmetry of the indole “spacer” makes both the syn and 
anti diastereoisomers entail an atropisomeric pair. A stereodynamic analysis of such new 
atropisomeric nitroindoles has been done resolving atropisomers by chiral HPLC and 
determining their absolute configuration and the rotational barriers of the indole–naphthyl 
axes.[4] 
This work, within an Erasmus+ project, demonstrates also the photochemical activity of 
electron donor-acceptor (EDA) complexes providing a way to generate radicals under mild 
conditions. This strategy has recently found application in chemical synthesis. Reported 
methods classically relied on the formation of intermolecular EDA complexes. Herein, we 
further expand the synthetic utility of this strategy demonstrating that indole-tethered ynones 
form an intramolecular electron donor-acceptor complex that can undergo visible-light-induced 
charge transfer to promote thiyl radical generation from thiols.[5] This initiates a novel radical 
chain sequence, based on dearomatizing spirocyclization with concomitant C–S bond 
formation. Sulfur-containing spirocycles are formed in high yields using this simple and mild 
synthetic protocol, in which neither transition metal catalysts nor photocatalysts are required. 
The proposed mechanism is supported by various mechanistic studies, and the unusual radical 
initiation mode represents only the second report of the use of an intramolecular electron donor-
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1.1. N-Heterocyclic compounds. 
Heterocycles are cyclic structures with two or more different kinds of atoms in the ring; 
depending on the ring size, the nature and number of the heteroatoms, the possible heterocyclic 
systems are limitless: for this reason, it is not surprisingly that they constitute the largest and 
most varied family of organic compounds.[6] Furthermore, a valuable balance between chemical 
stability and reactivity, the latter essentially due to the electronic distribution (polarization) 
within a C-Het bond, makes heterocycles very effective building-blocks in organic synthesis[7] 
and most privileged final structures in, e.g., the pharmacological or biological fields. Other 
important applications of heterocyclic compounds encompass their use as anticorrosive agents, 
agrochemicals, herbicides, fungicides, photostabilizers, photographic sensitizers and 
developers, copolymers, dyestuff, sensitizers, fluorescent whiteners, booster agents, flavouring 
agents, and antioxidants and vulcanization accelerators in the rubber industry. [8] 
Among heterocycles, a prominent role is undoubtedly played by N-heterocycles, which 
are, indeed, omnipresent in nature, playing essential roles in all living systems: pyrimidine and 
purine bases of DNA and RNA, heterocyclic rings contained in three of the essential amino 
acids (proline, histidine, and tryptophan) found in enzymes and proteins, several vitamins and 
cofactors (thiamine, nicotinamide, riboflavin, folic acid, biotin, just to cite some), pigments 
(chlorophyll) and hormones (serotonin and histamine) are noticeable examples of their vital 
roles.[9] 
This wide distribution in nature is strictly connected primarily to the broad spectrum of 
pharmacological activities that such compounds display. As a matter of fact, besides a vast and 
diversified natural production, nowadays, the large majority of pharmaceuticals are N-
heterocyclic compounds synthesized by mimicking nature, with widespread use as anticancer 
agents, analeptics, analgesics, hypnotics, and vasopressor modifiers.[10] 
Conceivably enough, this range of applications has stimulated during the years the design 
of efficient synthetic methodologies.[11] In this scenario, heterocyclic chemistry (and N-
heterocyclic chemistry, in particular) represents one of the most valuable sources of novel 
compounds with the most diverse physical, chemical and biological properties. 
1.2. Indoles: occurrence and significance. 
In the general field of heterocycles, the possible fusion of two or more rings leads to a 
range of polycyclic structures. Indole is an example of an aromatic N-heterocyclic compound 
with a fused bicyclic structure, consisting of a six-membered benzene ring fused to a five-
membered pyrrole ring.  
Isolated the first time by Baeyer from the reaction of indigo with a mixture of sulfuric 
acid and sulfuric anhydride,[12] indole (indigo+oleum) represents one of the most ubiquitous 
heterocyclic structures both in nature, where it is widely present in plants, and in industry, as 
an important core of agrochemicals, functional polymers/sensors, fragrances, and dyes.[13] 
However, the significance of indole derivatives is best highlighted by their biological 
applications.[14] To catalogue the complete biological activity range of indole derivatives is 
nearly impossible, and only some indications about the scope of such activities are reported in 
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Figure 1. Tryptophan is an essential amino acid. It is degraded by higher plants to heteroauxin, 
a plant growth-regulating hormone, and by bacteria to tryptamine, which is the start for some 
of the condensed ring alkaloids. Serotonin and melatonin are key neurotransmitters in the 
central nervous system. Ondansetron is an indole-based drug used for the suppression of nausea 
and vomiting caused by cancer chemotherapy and radiotherapy. Oxypertine is an antipsychotic 
and antidepressant used in the treatment of schizophrenia. Arbidol is an antiviral treatment for 
influenza infection. The hallucinogenic activity of lysergic acid diethylamide (LSD) is well 
known. Several anticancer drugs contain an indole core, the most famous of which are the 
pervinca alkaloids vinblastine and vincristine, both of which continue to be important drugs for 
the treatment of Hodgkin’s disease, childhood leukemia, and other types of cancer. 
 




1.3. Nitroindoles: occurrence and significance.   
Although, as reported before, the indole motif can be considered one of the most 
widespread N-heterocycles in nature, the natural occurrence of nitrated indole is definitely 
scanty.[1]  
Thaxtomin phytotoxins, generated as microbial metabolites, are a rare example of natural 
compounds possessing a unique 4-nitroindole moiety, essential requirement for their 
phytotoxicity.[15] They have been found in the common potato scab infected by the soil 
bacterium Streptomyces scabies.[16] During the last year, thaxtomin A (Figure 2), the most 
predominant and active member of such a family, attracted attention due to its herbicidal 
activity.[17] 
The first total synthesis of thaxtomin A was reported in 2013,[18] where the 4-nitroindole 
moiety was synthetized by Pd-catalyzed direct coupling of an aldehyde with 3-nitro-2-
iodoaniline as reported later (Scheme 2, d). 
 
Figure 2. Thaxtomin A: a natural 4-nitroindole derivative. 
Besides the thaxtomins discussed above, the only other naturally occurring nitroindole 
appears to be a 3-nitroindole isolated from the Arctic sea lice bacterium Salegentibacter sp. 
T436 along with 18 other aromatic nitro compounds.[19]  
Despite the scanty presence of nitroindoles in nature, thanks to the coupling of the 
properties of the nitro group and of the indole moiety, nitroindoles are anyway attractive targets 
in organic synthesis as reactive intermediates, also due to the possible transformations of the 
nitro group into different other valuable functionalities, besides to its reactivity-affecting and 
group-orienting effects.[1] Although reduction of the nitro group is a key transformation widely 
used to access the corresponding aminoindoles, often in turn precursors of other compounds[20] 
(such as, e.g. biologically active compounds[21]), nitroindoles have demonstrated during the 
years to be valuable precursor of fused nitrogenated polycycles e.g. via [3+2] dearomatizing 
annulation processes,[22] multicomponent heteroannulations,[23] and multicomponent domino 
cycloadditions.[21]  
Already since 1973, Garcia et al. transformed 1-methyl-3-nitroindole-2-carboxylic acid 
into several [1,4]diazepino[6,5-b]indoles 1 (Figure 3, a).[24] 2-Methyl-4-nitro-1H-indole has 
been used for the first generation supply route of 2AZD1981 (Figure 3, a),[25] an AstraZeneca 
inflammatory drug. In 2019, Liangce Rong et al. reported a novel method for the synthesis of 
nitrogen-containing spiro compounds 2 (Figure 3, a) directly from 5-nitroindole via an in situ 
reduction and multicomponent cyclization reaction.[26] Moreover, derivatives of 5-nitroindole 
are used in the synthesis of nitrazepam (Figure 3, b),[27] an hypnotic drug. On the other hand, 
derivatives of 6-nitroindole are used in the synthesis of arnoamine B (Figure 3, a),[28] a 




Figure 3. a) Fused nitrogenated polycycles synthetized from nitroindoles: nitrogen derived 
from the original nitro group being indicated in green; b) the hypnotic drug nitrazepam. 
The nitro group has also proven to be a valuable pharmacophore,[29] possibly thanks to 
partially reduced forms. Biological evaluation of 4-nitroindole derivatives has shown activity 
as 5HT2A receptor agonist.
[30] 5-Nitroindole is used as a universal base analogue in 
oligonucleotides (Figure 4) thanks to its ability to replace any of the four natural bases without 
significantly destabilizing neighbouring base-pair interactions or disrupting the expected 
functional capability of the resulting modified oligonucleotide. Incorporation of universal bases 
into oligonucleotides is desirable in cases when either imprecise or random base-pairing is 
required, and the resulting mis-matched complements need to be stable.[31] 
 
Figure 4. 5-Nitroindole as a universal base analogue in oligonucleotides. 
In addition, in material science, electro polymerization of 6- and 5-nitroindoles has 
received increasing attention due to the potential applications of the resulting conducting films 
in various domains like electrochemical sensors, green-light-emitting materials, electro-
catalysis, anode materials in battery and anticorrosion agents.[32] Structural studies showed that 
the polymerization occurs mainly at 2,3-positions.[33] Because the nitro group on the backbone 
can be easily reduced to amino group, the properties of inherently conducting polymers may be 
modified. Thus, the introduction of the nitro group on the main backbone will provide a novel 
approach for the post-functionalization of inherently conducting polymers.[34] 
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1.4. Nitroindoles: synthesis. 
Following the literature on the preparation of nitroindoles, it is possible to identify three 
main different approaches: 1) direct nitro functionalization of a pre-existing indole nucleus 
(Figure 5, pathway a); 2) ex-novo construction of the pyrrole ring onto a pre-existing benzene 
ring (Figure 5, pathway b: heteroannulation); 3) ex-novo construction of the benzene ring onto 
a pre-existing pyrrole ring (Figure 5, pathway c: benzannulation).  
 
Figure 5. The three main methodologies of nitroindole synthesis. 
1.4.1. Direct nitration of indoles.  
Direct nitration represents the traditional procedure to get nitroindoles.[1] Such approach, 
however, suffers from harsh reaction conditions due to the need for strong acids, poor 
regioselectivity, poor functional group compatibility, possible over nitration which leads to 
mixtures of regioisomers, limitation to the nitration of the more reactive pyrrole ring, while the 
nitration of the benzene ring is rarely achieved and limited to C2,C3-disubstituted indoles or 
indoles with an electron withdrawing group at C3.[35] Indeed, while indoles nitrated on the 
pyrrole ring are easier to be obtained, indoles nitrated on the benzene ring, especially with an 
unsubstituted pyrrole ring, are a very challenging target (Scheme 1, a).  
Direct nitration of indolines followed by a dehydrogenative step represents a possible 
alternative pathway to indoles nitrated on the benzene ring (Scheme 1, b).[36] 
In view of the advances in metal catalysis, an alternative way to get direct CH bond 
nitration is represented by regioselective metal-catalyzed nitration, e.g. Cu[37] or Co[38] catalysis. 
Buchwald, on the other hand, reported a Pd-catalyzed nitration of 6-chloroindole leading to 6-
nitroindole in good yields (Scheme 1, c).[39] 
Very recently, Jian-Ping Zou reported a transition metal-free, direct and selective radical 
C3-nitration of indoles using NaNO2 as NO2 source and with the mediation of K2S2O8 as 
oxidant (Scheme 1, d).[40] 
During the last years, enzymatic nitration strategies have been developed as well.[41]  
Yousong Ding recently reported for the first time a whole-cell nitration system for the 
production of 4-NO2-L-tryptophan analogues, by designing and expressing the biosynthetic 
pathway in Escherichia coli. Such structures are useful building blocks for synthesizing 




Scheme 1. Examples of direct nitration approaches. 
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1.4.2. Heteroannulation approach. 
Despite the recent advances in metal-catalyzed direct CH bond nitration, the ex-novo 
construction of the heterocyclic pyrrole ring onto a pre-existing benzene has been the most 
common synthetic approach in literature to access nitroindoles.  
A comprehensive classification of such cyclization protocols, as suggested by 
Sundberg,[43] could be done depending on the possible disconnections we can retrosynthetically 
draw on the pyrrole ring for its ex-novo construction (Figure 6). 
The first two types of cyclizations, involving the introduction of C2 and C3 carbon atoms 
or C2 carbon atom respectively, are the most common ones. Formation of N-C2 bond represents 
usually the last cyclization step of the major part of intermediates originated from the first two 
kinds of cyclization: for this reason, category 3 is considered a common approach as well. For 












Figure 6. The possible retrosynthetic disconnections of the pyrrole ring.[39] 
Disconnection 1 
The Fischer synthesis represents, from 1883, the main synthetic route to indoles;[44] in the 
specific case of nitroindoles, indeed, several o-, m- and p-nitrophenylhydrazones derived from 
ketones were cyclized in hot concentrated acid to the corresponding nitroindoles.[45] The 
method allows to access to indoles nitrated at any of the benzene ring positions, i.e. challenging 
positions in direct nitration reactions as mentioned above; it cannot be used, though, for the 
preparation of nitroindoles unsubstituted at pyrrole positions. In addition, by-products, low 
yields and mixtures of regioisomers, sometimes difficult to separate, are further drawbacks of 
the Fischer indole synthesis.[46] Despite this, the Fisher cyclization is still a key step for the 
synthesis of biologically active compounds. Narayana, in 2005, reported the synthesis of some 
1,3,4-oxadiazolyl nitroindoles with anti-inflammatory activity after a modified Fischer 
cyclization of ethyl pyruvate nitrophenyl hydrazones to ethylnitroindole-2-carboxylates,[47] as 
originally reported by Singer[46c] and Parmerter[45] in the fifties. The same Fischer cyclization 
of ethyl pyruvate nitrophenyl hydrazones 13 to ethylnitroindole-2-carboxylates 14 represented 
a key step used by El Kihel, in 2013, for the synthesis of (3,5-dimethyl-1H-pyrazol-1-yl) (7-
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nitro-1H-indol-2-yl)ketone derivatives 16, which attract great interest due to their varied and 
significant pharmacological effects (Scheme 2, a).[48]  
Another general and versatile approach to the nitroindole ring construction appears to be 
vicarious nucleophilic substitution (VNS) in nitroarenes and subsequent cyclizations.[49] By 
means of carbanions bearing a leaving group at the α-position, VNS introduces substituents into 
nitroarenes enabling replacement of hydrogen (or halogen)[50] in the position ortho and/or para 
to the nitro group.[49] The obtained ortho-nitrobenzyl derivatives are well suited as starting 
materials for the synthesis of heterocycles, particularly indoles. Thus, Mąkosza, in 1984, 
reported VNS in m-nitrobenzoisonitriles with chloromethyl aryl sulfones followed by 
cyclization directly to give substituted 4- and/or 6-nitroindoles.[51] In 2012, Wojciechowski 
reported the synthesis of 6-nitro-1-hydroxyindoles 19 after tin(II) reduction of 2,4-dinitrobenzyl 
ketones 18 obtained from a VNS of 1,3-dinitrobenzene 17 with α-chloroalkyl ketones (Scheme 
2, b).[52] 
Alternatively, direct condensation of 3-nitroanilines with ketones[53] or nitriles[54] 
represents a simpler method to access to 4- and/or 6-nitroindoles. These novel indole ring 
constructions include the nucleophilic substitution of hydrogen (or halogen) in the 
nitroaromatic ring by an enolate anion or a nitrile carbanion with subsequent cyclization 
(Scheme 2, c). 
The Pd-catalyzed direct coupling, of the ortho-iodoaniline 24 with the aldehyde 23, has 
represented, in a recent work, a key step for the first total synthesis of thaxtomin A (Scheme 2, 
d)[18] 
Moreover, nitroindoles can be prepared by the Bartoli method from dinitrobenzene by 
reaction with a vinyl Grignard (Scheme 2, e).[55] 
Disconnection 2 
In past years, 2,4,6-trinitrotoluene (TNT) 28 has demonstrated to be a powerful starting 
material for the synthesis of 6-nitroindoles, and 4,6-dinitroindolezoles.[56] Generally, these 
protocols require a first condensation step of TNT with an aldehyde to give the corresponding 
stylbene. Substitution of one of the ortho-nitro groups with the azido group leads to the 
corresponding o-azidostylbene which after thermolysis leads to the final nitroindole (Scheme 
3, a). However, TNT is an explosive that should be handled with great care. For this reason, the 
use of TNT as a start to nitroindoles is nowadays obsolete.  
Given the above disadvantages, compounds similar to TNT and not explosive (so-called 
‘‘TNT surrogate’’) in which one nitro group is replaced with another group, e.g. CF3 or SR, 
have been used into the Leimgruber–Batcho indole synthesis as an alternative method for the 
synthesis of nitroindoles starting from o-nitrotoluenes. The first step is the formation of an 
enamine using N,N-dimethylformamide dimethyl acetal, the nitroindole being then formed in a 
second step by reductive cyclization (Scheme 3, b).[57] 
Concerning nitration on the pyrrole ring, Gribble, in 1997, reported the synthesis of 2-
nitroindoles 38 via the Sundberg Indole synthesis, which involves the thermolysis of β-
substituted-o-azidostyrenes 37.[58] More recently, Driver reported the same formation of 
nitroindoles from β-substituted-o-azidostyrenes 37 in the presence of rhodium(II) carboxylate 
complexes,[59] but in this case only the selective formation of 3-nitroindoles 39 has been 
detected due to the catalyzed migration of the NO2 group from the original C2 carbon atom 














Actually, the major part of intermediates originated from the synthetic methods reported 
before (e.g. Fisher, Bergman, Reissert, Sundberg intermediates) performs disconnection 3 as 
the last step for the ex-novo construction of the pyrrole ring.  
Interestingly, this kind of disconnection is shown in a very recent work of Shu-Jiang Tu 
and Bo-Jiang in which they reported a silver-catalyzed nitration-annulations of 2-
arylalkynylanilines 40 with tert-butyl nitrite (TBN) as a mild, easy-to-handle nitrating reagent 
for the tunable selective synthesis of 5- or 7-nitroindoles (Scheme 4, a).[60] 
 
Disconnection 4 
The Madelung synthesis, a base-catalyzed thermal cyclization of N-phenylamides, is one 
of the few reactions that produce indoles by closure of C2- C3 bond.[61] 
 Special cases of such Madelung reaction are the ring closure reactions used by Bergman 
for the synthesis of a variety of 4- or 6-nitroindoles prepared, respectively, from imidate, 
amidine, and sec-anilide derivatives of 2-alkyl-3- or 5-nitroanilines by a base-induced 
cyclization promoted by dialkyl oxalates at room temperature (neither 5- nor 7- nitroindoles 
could be synthesized using this method) (Scheme 4, b).[62]  
Disconnection 5 
Oxidative cyclizations of N-aryl enamines and N-aryl imines are the common approach 
belonging this disconnection class.[63] Pd-catalyzed oxidative cyclization of N-aryl enamines 
have recently developed for the efficient synthesis of 2-nitroindoles.[64] 
Although these approaches possess an operationally simple, highly atom-economical and 
broad substrate scope, they are limited to the requirement of expensive Pd catalysts and 
additives. Thus, a new metal-free nitrative oxidative cyclization of N-aryl imines 45 with tert-
butyl nitrite have been reported as an alternative method (Scheme 4, c).[65] 
Disconnection 6 
The Cadogan-Sundberg reaction, i.e. deoxygenation of o-nitrostyrenes or o-nitrostilbenes 
with trialkyl phosphite or trialkylphosphine and subsequent cyclization of the resulting 
intermediate nitrene to form indoles, is a possible synthetic method forming connection 6.[66] 
Although Cadogan reaction is nowadays a good way to build up a new N-containing ring into 
a system, it has not been a common route to access nitroindoles. As an old example, Russell, in 
1991, reported the cyclization of 1,1-dinitro-2,2-diphenylethylene 47 to 2-nitro-3-phenylindole 










1.4.3. Benzannulation approach. 
A more recent approach to indoles is the ex-novo construction of the benzene ring onto a 
pyrrole derivative (i.e. benzannulation): such procedure has started to be successfully applied 
to diverse 4-, 5-, 6- or 7-substituted indoles by means of different building blocks and reaction 
typologies, often exploiting metal catalysis.[68] 
In this scenario, though, nitro indoles are practically absent, except for a very recent report 
on a two-step procedure to 6-nitroindoles 52 where a β-nitro ketone 49 with a protected 
carbonyl provides a nitrated C3 building-block for an overall annulation occurring through an 
initial condensation with a suitable 2-pyrrolecarbaldehyde 50 followed by a second, 
intramolecular condensation (Scheme 5).[69] The method is based on the peculiarity of the flow 
chemistry and microwave technology. 
 
Scheme 5. 6-Nitroindoles via annulation onto pyrrole by means of a C3 building block.  
In this unexplored context of benzannulation methodologies for the synthesis of 




2. SCOPE  
The present Ph.D. project is part of a long-standing project carried out at Genoa 
University by the ORSA research group, whose focus is on the study of the reactivity of nitro 
and dinitro-1,3-butadienes, obtained from the initial ring opening of nitro- and 
dinitrothiophenes, respectively. Previous papers in the series have demonstrated the synthetic 
potential of such nitrobutadienes to develop a preparative method for diversely functionalized 
and versatile heterocyclic targets (Scheme 6).[70] 
 
Scheme 6. 
In a precedent work, such nitrobutadienes have already demonstrated to be valuable 
nitrated C4 building-blocks for a benzannulation onto indole leading to nitrocarbazoles (Scheme 
7, a).[71]  
Proud of the results achieved, the aim of the present work has been a study of reactivity 
of mono and dinitro-1,3-butadienes towards pyrrole, in order to build up a new protocol into 
the unexplored context of benzannulation methodologies for the synthesis of nitroindoles. The 
targets, never reported so far, appear of sure interest because of their pattern of substitution not 
easy to be obtained otherwise. Due to the possible further elaborations the nitro group is 
promising for, the aim of the work has been also the application of the designed nitroindoles as 
valuable precursor e.g of fused nitrogenated polycycles (Scheme 7, b). 
In addition, during my Ph.D. I have had an Erasmus internship of six months at York 
University. Aim of the Erasmus project has been the development of a precedently-unreported 
visible-light promoted dearomatizing spirocyclization of indole-tethered ynones for the 
preparation of novel spiroindoles and/or spiroindolines (Scheme 7, c). Although they look like 
different projects, they find a point common in the use of the reactivity of indole derivatives in 









3. RESULTS AND DISCUSSION  
3.1. An unprecedented easy access to rare nitroindoles. 
Our study began carrying out an optimization of experimental condition on the model 
reaction between the bis(p-tolyl)dinitrobutadiene 53a and pyrrole, the main results from such 
preliminary screening being collected in Table 1. Under the reaction conditions previously 
employed for the benzannulation of indole [2,2,2-trifluoroethanol (TFE) at 50 °C: entry 1][71] 
an overall substrate conversion has been obtained. As in the case of carbazoles, a 
nitrosubstituted benzene ring is actually constructed, leading to a final mixture of three different 




Table 1. Results of reaction of 53a with pyrrole (2 equiv.) in different experimental conditions.a 
Entry Solventb T t 53a 56a + 57a 58a 59a Balance 
1 TFE 50° C 24 h - 20 40 - 60 
2 TFEc 50° C 24 h - 24 43 - 67 
3 TFE 50° C 1,5 h - 41 27 13 81 
4 TFE 50° C 45 min 6 6 7 49 68 
5 TFE 30° C 4 h 4 4 8 77 93 
6 TFE r.t. 48 h - 14 8 62 84 
7 HFIP r.t. 48 h - 23 28 - 51 
8 Toluene 50 °C then reflux. 24 + 48 h d - - - - 
aYields refer to chromatographically isolated compounds (or mixtures). bTFE = 2,2,2-trifluoroethanol; HFIP = 
1,1,1,3,3,3-hexafluoro-2-propanol. cUnder argon atmosphere. dOnly substrate evidenced on TLC, with at most 
traces of possible products. 
As oxidative steps are needed for the formation of the isolated products, the same reaction 
conditions have been performed under argon atmosphere (entry 2), demonstrating that the 
oxidant cannot be atmospheric oxygen: thus, as already observed in previous recent papers of 
ours,[70b, 71-72] the nitrite ion, deriving from elimination, must be responsible for the observed 
“endogenous” oxidation (see later in the text). 
Unfortunately, the low selectivity among the three nitroindoles and the complicated 
chromatographic isolation due to structural similarities represent practical drawbacks. Anyway, 
interestingly enough, lowering the reaction temperature has brought to evidence (TLC) the 
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formation of the intermediate 59a, which could be isolated (entry 5) in rather satisfactory yields 
at 30 °C. Such an outcome was actually rather unexpected, as no intermediate had been ever 
detected in the analogous benzannulation reactions of indole.[71] Further temperature decrease 
(entry 6) revealed to be unfavorable to the “interception” of 59a, while much poorer results 
were provided by the use of another fluorinated solvent such as 1,1,1,3,3,3-hexafluoro-2-
propanol (HFIP; entry 7). 
X-ray analysis of 59a testified for the 4,7 dihydro-indole reported in Figure 7, with an 




Figure 7. Structure and ORTEP of 59a; ellipsoids enclose 50% probability. 
Dihydroindole 59a has demonstrated to be a common precursor of the three different 
nitroindoles and its isolation allows us to optimize their final yields by means of separate 
follow-up procedures. Thus, overnight treatment of 59a with the strong base DBU (1,8-
diazabicyclo[5.4.0]undec-7-ene) in dichloromethane at room temperature very efficiently leads 
to the mixture of the two mononitroindoles (56a + 57a). On the other hand, overnight treatment 
of the same dihydrodinitroindole with the oxidant 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
(DDQ) in toluene at reflux leads to the dinitroindole 58a in excellent yield (Scheme 9). 
 
Scheme 9. Selective formation of mono- or dinitroindoles via interception of the common 
dihydro intermediate 59a. 
This protocol can be followed, with similar success, for dinitrodienes with different aryl 
and alkyl substituents, by suitably changing temperature and reaction time. 
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The dihydro intermediate could be isolated in acceptable or satisfactory yields (Scheme 
10) also from the 1,4-diaryl-2,3-dinitro-1,3-butadienes 53b, 53c and 4,5-dinitro-3,5-octadiene 
53g, although it normally suffers from more or less extensive decomposition during 
chromatographic purification: thus it was found in general more convenient to simply remove 
the solvent by rotoevaporation after disappearance (TLC) of 53, and then submit the residue to 
DBU-elimination or DDQ-oxidation (Table 2). 
 
Scheme 10. Isolation of 59 from the reaction of pyrrole (2 mol equiv.) with 53. Yields refer to 
chromatographically isolated compounds. Reported times refer to the maximal formation of 
59, as judged by TLC. 
Table 2. Results from the reaction of pyrrole (2 mol equiv.) with 53 in TFE at 30 °C, 
followed by one-pot DBU or DDQ treatment of the mixture rotoevaporated after the time 
reported in column 3, without the isolation of the dihydro intermediate 59.a 
Entry 53: Ar(R) tb,c 
Follow-up with DBUd Follow-up with DDQe 
56 + 57 58 56 + 57 58 
1 53a: p-Tolyl 4 h 78  7 70 
2 53b: p-MeOC6H4 6 h 58   57 
3 53c: m-ClC6H4 4 h 86  8 50 
4 53d: 1-Naphthyl
f,g 3 d 51 16 14 63 
5 53e: 2-Thienyl
f 2 d 58 16 17 68 
6 53f: Methyl 9 h 38 13  41 
7 53g: Ethyl 2 d 39 4  44 
aYields refer to chromatographically isolated compounds (or mixtures). bTime for the maximal formation of 
59, as judged by TLC. cAfter the time in column 3, TFE was removed before treatment for the alternative 
follow-up reactions, without further purification. dTreatment with DBU (1.1 mol equiv.)/CH2Cl2, rt for 24 h; 
yields refer to 53; in some case minor quantities of 58 were also isolated. eTreatment of 59 with DDQ (2 mol 
equiv.)/toluene at reflux for 24 h; yields refer to 53; in some case minor quantities of the 56+57 mixture was 
also isolated.  fMol equiv. of pyrrole = 4. gThe synthesis of 58d has been already described.[4] 
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Steric hindrance most likely contributes to slow down the annulation leading to 59d 
(Table 2, entry 4, Ar = 1-naphthyl), while electronic effects possibly play a significant role in 
the case of 59e. As far as the possibility to extend the synthesis to 4,7-dialkyl (di)nitroindoles 
is concerned, both the dimethyl derivative 53f (Table 2, entry 6) and the diethyl derivative 53g 
(Table 2, entry 7) furnish nitroindoles 56+57 or 58 in significantly lower yields, possibly also 
due to some loss during the TFE rotoevaporation prior to follow-up, as a consequence of a 
somewhat higher volatility of the relevant dihydro intermediates.  
The mixtures of regioisomeric mono-nitroindoles 56 and 57 for the diaryl derivatives a-e 
were separated by HPLC. Anyway, the direct assignment by X-Ray crystallography was 
feasible only for the 2 thienyl derivatives 56e and 57e: actually, good crystals were obtained 
for the minor regioisomer 56e, which was found to have the nitro group at C5 (Figure 8), thus 
assigning a 6 nitroindole structure to the major regioisomer 57e. 
 
Figure 8. X-Ray structure of the first eluted bis(2-thienyl) regioisomer from 53e (HPLC: 
Luna 5 μ C18(2) 100 Å, acetonitrile/H2O 90/10, 5 mL/min). 
For all the other compounds, NOESY experiments confirm that the 5-nitroindole 56 is, 
in any case, the minor component, 56:57 ratios most often falling within the 1:1 – 0.7:1 range. 
The HPLC and NOESY analyses reported in Figure 9 refer to the p-tolyl compound 56a. The 
NOESY traces 1) and 2) were obtained irradiating the NH and H-3 protons, respectively, to 
assign the H-15 and H-11 protons. Then, H-6 and H-5 protons of compounds 56a and 57a, 
respectively, were saturated. In this way, H-6 showed NOESY effect on H-15, and H-5 showed 
NOESY effect on H-11. 
Pleasingly, a simple silica-gel column chromatography allowed a satisfactory separation 
of the 56f/57f and 56g/57g couples. 
 
Mechanistic aspects of the benzannulation process: a proposed rationalization 
Any rationalization of the annulation mechanism should obviously justify the 





Figure 9. HPLC and NOESY analyses of mononitroindoles 56a and 57a. Trace 4) is relevant 
to the 1H NMR spectra in CDCl3. Traces 1), 2), 3) are the NOESY experiments irradiating 
NH, H-3, and H-6 or H-5 proton, respectively. 
A fully-concerted [4+2] cycloaddition can be reasonably excluded because, as a 
consequence of the expected diastereospecific process onto the E,E-1,3-diene, it would end up 
with the substituents at C4 and C7 syn to each other unlike the anti-configuration of 59a. Indeed, 
pyrroles are known to behave mostly as dienes,[73] and only a limited number of them act as 
dienophiles.[74] On the other hand, within a long-standing research based on the use of nitro- 
and dinitrobutadienes as building-blocks, we have never observed a behaviour of the four-
carbon skeleton of 53 as a diene: rather the single nitrovinyl fragment (C=C-N=O) can be 
involved in hetero-DA processes. Furthermore, no reaction occurring in an apolar solvent such 
as toluene (entry 8 of Table 1) is a further evidence that a fully-concerted mechanism, with no 
charge separation, is not involved.[75] 
On these grounds, a [4+2] not fully-concerted cycloaddition through the zwitterionic 
intermediate I possessing an inverted polarity[76] (Scheme 11, route a) and a two-step ionic 
mechanism involving consecutive (inter- and intramolecular) Michael-type additions (route b) 
can be hypothesized. In either case, a dehydrogenative step is required to complete the 
formation of 59 from II or IV, respectively. Whichever the actual pathway, the surprising 
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complete diastereoselectivity for the formation of 59 can be justified by the presumably higher 
stability of the anti configuration. 
 
Scheme 11. Mechanistic hypotheses for the formation of dihydroindoles 59. 
While route a) better justifies the double bond position found in the isolated 
dihydroindole 59 due to the re-aromatization of the pyrrole ring, route b) better justifies the 
oxidation steps of II or IV performed by endogenous nitrite ion: indeed, on intermediate III the 
intramolecular addition leading to IV (Scheme 11) could compete with elimination of nitrite 
and rearomatization of the pyrrole ring (Scheme 12). The effectiveness of nitrite as a leaving-
group could be favored by the acidity of TFE. A less efficient initial formation of III’ by 
concurrent electrophilic substitution at C3 of pyrrole would lead, in a similar way, to V’ 
(Scheme 12). 
 
Scheme 12. Rationalization of formation of the endogenous oxidant (HNO2) in TFE, in the 
absence of an added base. 
While Scheme 12 rationalizes the possibility to eventually obtain mononitroindoles in the 
normal conditions (TFE) within reaction pathways not having 59 as an intermediate, a further 
effort must be done in order to justify the formation of 56 and/or 57 from 59. In the experiment 
where the intercepted 59 is treated with DBU, most likely a base-catalyzed allylic isomerization 
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(driven by the attainment of an extended conjugation within a push-pull system) would precede 
HNO2 elimination (Scheme 13). On the other hand, in the normal reaction conditions (TFE, 
excess pyrrole) the amphoteric solvent itself should be the most effective base, although 
bifunctional catalysis cannot be excluded (possibly within a solvent cage). The properties of 
polyfluorinated solvents have been recently investigated[77] (oxidations and isomerizations, in 
particular, being favored processes), but a deeper mechanistic investigation would go beyond 
the practical significance of the results herein. 
 





A very interesting side project originated from the observation that, much as it happens 
in the more classical case of ortho-substituted biphenyls, the steric hindrance cooperatively 
played, in the bis(1-naphthyl)dinitroindole 58d, by the two nitro groups and by the N(1)H and 
C(3)H moieties of the pyrrole ring forces the naphthyl groups out of the indole plane, thus 
generating two stereogenic axes; furthermore the asymmetry of the indole “spacer” makes both 
the syn and anti diastereoisomers entail an atropisomeric pair (Figure 10), while in other cases, 
such as the biphenyl system, where the two phenyl rings are directly linked to each other, the 
syn diastereoisomer is a meso form and the anti is racemic.  
 
Figure 10. The four atropisomers generated by the two stereogenic axes in 58d. 
Atropisomerism, i.e. the optical activity generated by a chiral axis, was first recognized 
by Christie and Kenner in 1922[78] and later its definition was refined by Oki.[79] This 
phenomenon has been largely overlooked as an alternative source of stereoisomerism for many 
decades. However, the situation changed with the preparation of atropisomeric catalysts[80] and 
with the discovery of many bioactive natural compounds containing stereogenic axes.[81] More 
recently, Clayden and LaPlante underlined the pharmaceutical implications of atropisomerism 
in drug discovery.[82] On the other hand, enantiopure 1,2-diamines are found in biologically 
active molecules and are largely employed as ligands for organometallic enantioselective 
catalyst.[83] 
A stereodynamic study of compound 58d was carried out in collaboration with the 
research group of Professor Mazzanti of Bologna University.[4]  
In order to optimize the ground state geometry, DFT calculations [B3LYP/6-31g(d) level 
of theory][84] showed the 1-naphthyl rings not perpendicular to the plane of the indole; hence, 
for each atropisomer, four different conformations have to be considered corresponding to the 
four combinations of the two dihedral angles that can be smaller or larger than |90|°.[85] 
However, in the case of the syn diastereoisomer, the two conformations where both angles are 
larger or smaller than 90° do not correspond to energy minima. This occurrence is due to the 
presence of the two nitro groups in positions 5 and 6. In the optimized structures, the two 
29 
 
naphthyl rings and the two nitro groups are linked in a geared system,[86] which means that the 
movement of one naphthyl ring causes the movement of the two nitro groups and eventually 
the rotation of the second naphthyl ring. In the anti diastereoisomer, for the same reason, only 
the conformations with the two angles smaller or larger than |90|° are energy minima (Figure 
11). DFT calculations suggested that the syn and anti diastereoisomers have very close energies 
and they should be both populated.  
 
Figure 11. The four ground states of compound 58d. Only one atropisomer is shown for each 
conformation. The numbers are the values of the dihedral angle defined by the quaternary 
carbon bearing the nitro group on the indole and the quaternary carbon of the 1-naphthyl ring. 
Energies are given in kcal mol–1 as ZPE-corrected enthalpies. 
Calculations were also run to evaluate the two rotational barriers of the 1-naphthyl rings. 
For both barriers the calculated value exceeds 29 kcal mol–1 (29.78 and 29.76 for C4-naphthyl 
rotation and C7-naphthyl rotation, respectively); hence, both stereogenic axes should be 
configurationally stable at room temperature. 
Experimental rotational barriers can be evaluated by kinetic experiments run on the 
enantiopure diastereoisomers of 58d. However, a good separation of them on a chiral stationary 
phase (CSP) HPLC was not obtained, despite many efforts with different HPLC columns and 
conditions. Fortunately, such separation has been possible after Boc protection (58d → 61, 
reaction II in Scheme 14) of the NH (Figure 12). 
 
Figure 12. HPLC chromatogram of 61 on Chiralpak AD-H, 250x4.6 mm, n-hexane/i-PrOH 




After preparative chromatography, by NMR the first two eluted peaks have demonstrated 
to be diastereoisomers. The two enantiopure diastereoisomers of 58d have been, then, obtained 
after Boc removal (61 → 58d, reaction III in Scheme 14).  
The rotational barriers can be evaluated by kinetic experiments followed by HPLC and 
NMR. For this analysis it should be pointed out that the two rotational barriers have different 
stereochemical effects: the lower energy barrier converts one diastereoisomer into the other (a 
process which can be followed by NMR), while the higher energy barrier exchanges the 
atropisomers due to the presence of the second stereogenic axis (a process which can be 
followed by CSP-HPLC). However, in the case of compound 58d, the suggested calculated 
barriers are very similar and a mixed situation is conceivable. While the diastereomerization 
was actually performed following the process by NMR (32.6 kcal/mol, Figure S10 in 
Experimental Section), the impossibility to obtain a good HPLC separation did not allow to 
perform a simple kinetic experiment to obtain the racemization barrier.  
To overcome this additional problem, we figured the preparation of two compounds 
(Scheme 14) where one of the two barriers was raised by replacing N(1)H with N-Me 
(compound 60) and the C(3)H with a C-Br (compound 63). The presence of additional steric 
hindrance on the indole core should make the two rotational barriers for the naphthyl groups 
much more different, so the enantiomerization barrier should be easily distinguishable from the 
diastereomerization one.  
 
Scheme 14. Synthetic plan to overcome problems related to the separation of the four 
atropisomers of 58d and to the distinguishable determination of enantiomerization and 
diastereomerization barriers. 
For 60 the diastereomerization barrier was followed by NMR starting from a sample of 
the last eluted stereoisomer 60(d) (letter refers to the elution order of the HPLC reported in 
Figure S11 of Experimental Section) that was heated at +130 °C and +140 °C and checked at 
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fixed times, following the growth of the second diastereoisomer (Figure S12 in Experimental 
Section). By applying a first-order reversible kinetic equation, a rate constant of 1.44x10-5 s-1 
was derived at +130 °C (and 3.16x10-5 s-1 at +140 °C), yielding a rotational barrier of 32.8±0.15 
kcal/mol by means of the Eyring equation. After 18 hours at +140 °C the diastereomerization 
was complete, and the sample was checked by CSP-HPLC, showing the presence of two main 
diastereomeric peaks [60(a) + 60(d)], and two tiny peaks of the remaining stereoisomers 60(b) 
and 60(c) (0.7% and 0.8%, respectively, Figure 13). The enantiomerization barrier was 
estimated by considering 0.75% of conversion, yielding a value of about 37.5 kcal/mol, in 
agreement with the difference suggested by DFT calculation (Table 3).  
 
Figure 13. CSP-HPLC of compound 60d after thermal equilibration at +140 °C for 18 h. 
(Chiralpak AD-H column, eluent n-hexane/i-PrOH (9:1), 1 mL/min). 
The same approach was used to analyze compound 63, where the diasteromerization 
barrier was found to be 33.1 ± 0.15 kcal/mol and the enantiomerization was found to be above 
38 kcal/mol.[87] 
Experimental and calculated enantio- and diastereomerization barriers are summarized in 
Table 3.  
Table 3. Experimental and calculated Interconversion Barriers.a 
 Experimental Calculatedb 
 enant. diast. enant. diast. 
58d 32.6 32.6 29.79c (C7) 29.76c  (C4) 
60 37.5 32.8 33.8c  (C7) 30.2c  (C4) 
63 >38 33.1 33.4d 
 
(C4) 30.7 d (C7) 
aThe calculated energies are reported in kcal/mol. b In parenthesis the stereogenic axis involved. cAt 
the B3LYP/6-31g(d) level of theory. d At the B3LYP/6-311g(d,p) level of theory.  
To compare the diastereoisomerization barriers, the kinetic experiments were run by 
keeping the samples of 58d, 60, and 63 in the same oil bath, in order to avoid any temperature 
difference between the experiments. Within this framework, the error due to the temperature is 
ruled out and any difference in the rate constants is meaningful. Looking at the calculated results 
reported in Table 3, the rotational barrier of the 7-naphthyl ring in 58d is higher than that of the 
4-naphthyl. This implies that the NH exerts a slightly larger steric hindrance with respect to the 
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CH in position 3 of indole. It should be noted that the experimental diastereoisomerization 
barrier of 58d is lower than the diastereoisomerization barrier of 60 and 63. This apparent 
discrepancy confirms, as a matter of fact, that the two energy barriers in 58d are very similar. 
Indeed, if the barriers were identical, the probability for diastereoisomerization by the rotation 
of one naphthyl group would be double; hence, the corresponding barrier would be lowered by 
a factor of RTln2.[88] 
Absolute configurations were assigned by the combination of X-ray crystallography, 
ECD spectra, and TD-DFT calculations.[4] (Table 4). 
Table 4. Summary of the Absolute Configurations.a 
  a b c d 
58d 4M,7M 4P,7M 4P,7P 4M,7P 
60 4M,7M 4P,7P 4M,7P 4P,7M 
61 4M,7M 4P,7M 4P,7P 4M,7P 
62 4M,7M 4P,7M 4P,7P 4M,7P 
63 4M,7M 4P,7M 4P,7P 4M,7P 
aLetters refer to HPLC elution order. 
Instead, in the cases of 1-naphthyl derivatives 56d and 57d, there is just one stereogenic 
axis, due to the large steric hindrance between the naphthyl moiety and the NO2 group, 
generating two atropisomers for each regioisomer. The atropisomers were separated by means 
of CSP-HPLC (Figure 14, left). The absolute configurations were determined by chiroptical 
Electron Circular Dichroism (ECD), simulating the ECD spectrum with TD-DFT calculations 
(see Experimental Section): for both 56d and 57d the calculated spectrum for the M absolute 
configuration is in agreement with the experimental spectrum of the first eluted (Figure 14, 
right). 
 
Figure 14. Left: CSP-HPLC chromatograms of compounds 56d and 57d; right: experimental 
and calculated ECD spectra, for the first eluted and M absolute configuration, respectively. 
33 
 
3.2. Sequential annulations to novel pyrrolo[3,2-c]carbazoles. 
In the previous section, I have reported the use of symmetric 2,3-dinitro-1,3-butadienes 
in a mild, metal-free, and original benzannulation onto pyrrole to form 4,7-disubstituted indoles 
mono or dinitrated on the otherwise not-easily-accessible benzene ring. The possibility to 
intercept an intermediate common precursor for either mono- (56 and 57) or dinitroindoles (58) 
allowed a definitely better selectivity to the whole process (Scheme 15, previous work).[2]  
Such interesting results have encouraged us to proceed in this research by studying the 
non-symmetric 2-nitro-1,3-butadienes as annulation agents of pyrrole (Scheme 15, this work). 
As I will show, new access to precedently-unreported 7-aryl-6-nitroindoles 64 has figured out, 
which have proven to be valuable precursors of pyrrolo[3,2-c]carbazoles 68, with an unusual 
type of fusion. Unlike the previous work, no intermediate has been ever detected.[3] 
 
Scheme 15. 
An optimization study of the experimental conditions on the model reaction between 
nitrobutadiene 54a[70] (Ar = p-Tol) and pyrrole started using 2 mol equiv. of pyrrole in TFE at 
50 °C. The complete disappearance of 54a was observed by TLC after 24 h; the analysis of the 
chromatographed final reaction mixture highlighted the formation of three different indole 
derivatives (64a-66a, Scheme 16), 64a being by far the prevalent one (Table 5, entry 1). Despite 
the satisfying balance, we continued the optimization study hoping to get more selective 
reaction conditions. 
Increasing the equivalents of pyrrole, even if the reaction was faster (Table 5, entry 2), 
results were almost unchanged, in particular as far as the main product is concerned. We, then, 
decreased the temperature with the hope to intercept an unsaturated intermediate analogous to 
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the dihydroindole 59 of Figure 7. Anyway, while a progressive slowdown (entries 3 and 4) was 
obtained, absolute and relative yields were again almost unchanged without a possibility to 
observe any kind of intermediate. At the end of this screening, we judged those of entry 3 as 
the conditions of choice, as they allow a reasonable reaction time and a better yield of 64a. 
 
Scheme 16. Results from the reaction between the 2-nitrodiene 54a and pyrrole. 
Table 5. Search for conditions of choice in the reactions of nitrobutadiene 4a with pyrrole.a 









1 50 2 24 52 % 16 % 14 % 82% 
2 50 4 2.5 53 % 21 % 17 % 91% 
3 40 4 5 57 % 17 % 12 % 86% 
4 30 4 24 57 % 16 % 19 % 92% 
5 0 4 48 - - - b 
aYields reported are for chromatographically isolated compounds; bThe unreacted substrate was 
quantitatively recovered. 
We proceeded then to verify the scope of the reaction, applying the same conditions to a 
series of 2-nitro-1,3-butadienes substituted at position 1 with different Ar groups, Table 7 
showing the results obtained. It can be observed that the good selectivity and the satisfying 
balance evidenced for 64a were not exhibited by the whole series, being maintained only for 
64b, 64d, and, somewhat less so, for 64c and 64e. Particularly negative was the result for 64f, 
while for 64g a fourth product (67g) originates in a yield comparable to 64g. Longer reaction 
times were required by 64i, and after 7 hours the control TLC still showed traces of substrate. 
The data obtained until now reveal a not negligible effect exerted both by EWG and EDG 
substituents on Ar, so the best conditions for the model substrate do not have general validity. 





Table 6. Diene scopea 
 
Entry Ar  64  65  66  67  
1 54a: p-Tol 57 17 12  
2 54b: Ph: 60  10 10  
3 54c: p-MeOC6H4  44  17 13  
4 54d: m-ClC6H4  53  11 18  
5 54e: p-ClC6H4  42 8  15 18 
6 54f: p-MeSO2C6H4  19 nq
b nqb nqb 
7 54g:3,5-(CF3)2C6H3  22 10 11 25 
8 54h:1-Naphthyl  40 14 13 13 
9 54i: 2-Thienylc 33 7 11 14 
aYields reported are for chromatographically isolated compounds, unless otherwise specified; 
bObserved by TLC and hypothesized on the grounds of 1H NMR signals, but not quantified. cReaction 
time: 7h. 
The principal products 7-aryl-6-nitroindoles 64 have been never reported so far and 
appeared of sure interest because of a pattern of substitution not easy to be obtained otherwise. 
The nitro group at C-6 of the indole ring system is promising e.g. for further elaborations: for 
instance, the application of the classic Cadogan reaction conditions[89] could hopefully build up 
unusual pyrrolo[3,2-c]carbazoles (Scheme 17), very rarely reported before in the literature[90] 
notwithstanding, many other similar scaffolds, different from the kind of fusion between 
pyrrole and carbazole, have been described. For instance, some pyrrolo[2,3-a]carbazoles have 
been recently synthesized and tested for their pharmacological properties (Pim kinase inhibitory 
potencies),[87] while the pyrrolo[2,3-c]carbazole scaffold characterizes the biologically active 
natural compounds dictyodendrines.[91] Encouraged by the wide diffusion of fused carbazole 
scaffolds among natural or synthetic biologically-active compounds, we submitted compound 
64a to reflux in triethyl phosphite. The reaction went on smoothly to give the expected 
compound 68a, in a 75% yield (Scheme 17). For the extension of the Cadogan reaction to other 
derivatives, we excluded those items for which, because of the poorer results of the 
benzannulation, the two-step procedure would be inconvenient. The compounds obtained and 




Scheme 17. Results obtained in the Cadogan reaction (triethyl phosphite at reflux, 5 h, under 
Ar) applied on 7-aryl-6-nitroindoles 64; yields are for chromatographically isolated 
compounds. 
In order to rationalize the formation of the observed products, the absence of any isolable 
intermediate does not let the discussion to have more than just a speculative significance. 
As already ascertained in other processes studied before,[70a] the nitrovinylic moiety is the 
more reactive electrophilic site within butadienes 54: thus, the nuclophilic attack of pyrrole 
gives presumably origin to the Michael adduct 6, whose most reasonable evolutions is reported 
in Scheme 18. The cyclization step could in principle generate the tetrahydroindole I (through 
a 6-endo-trig Michael addition) or the dihydroindole II (through a SNV 6-exo-trig process). A 
third possible way (SNV with ICD)
[92] to give III could be labeled again as a 6-endo-trig 
process. The main products (64-66) actually observed can find in II an obvious common 
precursor, while I could be the precursor of all the four possible products. As far as III is 
concerned, it could at most be a competitive precursor only of 66. 
 
Scheme 18. Conceivable evolutions of 69 according to the observed products. 
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As a matter of fact, experimental results in previously studied systems, as well as 
Baldwin’s rules[93] encourage to consider the intermediate II as the most likely one, although it 
is only through I that 67 can originate. Thus, the observed distribution could be the result of a 
competition between these two alternative cyclization ways, rather than the consequence of 
different evolutions of I, with II anyway playing a significant role. 
Actually, as considered also in the analogous reactions of dinitrobutadienes 52 (Scheme 
11, route a) we cannot exclude an alternative cyclization mechanism where the initially formed 
zwitterionic form of 69 (69’) could evolve through an ionic cycloaddition in which the hexa-
atomic ring closes with an inversion of polarity, generating IV, not yet aromatic in the penta-
atomic ring (Scheme 19). From this tetrahydroindole, processes involving tautomerizations, 
elimination(s) of acid, oxidative aromatizations (not necessarily in this sequence) would 
generate all the observed products. 
 
Scheme 19. Alternative ionic cycloaddition to tetrahydroindole IV. 
While in the cited case of dinitrobutadienes 52 this occurrence would better fit with the 
isolation of intermediate 59 (Scheme 11), it should be recalled that no intermediates were ever 
isolated herein, although a zwitterion would be perhaps more justified than in the previous 
system. Actually, the presence of the electron-withdrawing SO2Me group on C4 would increase 
the stabilization of the negative charge delocalized by the nitrovinylic moiety, making 
intermediate 69’ a better nucleophile and a weaker base. This last hypothesis seems more 
intriguing, but only the interception of IV, possibly by trapping with a suitable diene, could 




4.  ERASMUS PROJECT  
Within the Erasmus+ program, I had an internship of six months at the “Department of 
Chemistry” of York University under the supervision of Dr. William Unsworth. The project 
was focused on the development of a precedent-unreported visible-light promoted 
dearomatizing spirocyclization of indole-tethered ynones for the preparation of novel 
spiroindoles and spiroindolines. 
4.1. Spiroindoles and spiroindolines.  
A spirocompound is a chemical compound presenting a polycyclic structure in which at 
least two rings are linked together by one common atom. Spirocyclic compounds are unique 
because of their rigidity and three-dimensional geometries: spiroindolines and spiro-3H-indoles 
(also referred to as spiroindolenines) are important classes of spirocyclic compounds, present 
in a wide range of pharmaceuticals and biologically important natural alkaloids (Figure 14).[94] 
Spiroindolines and spiroindoles possess versatile reactivity which enables them to act as 
precursors for other privileged heterocyclic scaffolds,[95] including 1H-indoles, carbazoles, 
oxindoles, and polycyclic frameworks. 
 
Figure 15. Natural alkaloids containing the C2 or C3-spirocyclic indoline/indolenine core. 
Indoles can be spirocyclized at their 2- or 3- position to give C2-spiroindolines and C3-
spiroindoles/indolines. In both classes, the ring size and the number and nature of 





Figure 16. Different categories of spiroindolines and spiroindoles. 
The spirocyclic core structure in the field of indoles was first reported by A. Pictet and T. 
Spengler in 1911 as an intermediate, which rapidly underwent 1,2-migration to restore 
aromaticity.[96] The first successful isolation of a spiroindoline was achieved in 2010 by the 
research group of S.-L. You utilizing an Ir catalyst.[97] Since then, many synthetic strategies 
have been successfully applied for the synthesis of spiroindolines and spiroindoles.[94] In 
particular, Unsworth et al.[98] grouped the various synthetic strategies for the synthesis of 
spirocyclic indolenines into three main categories: (1) interrupted Fischer indolisations, (2) 
dearomatization reactions of indoles, and (3) condensation reactions.  
 
Figure 17. Spirocyclic indolenine synthetic strategies. 
The dearomatization of an indole precursor is, today, the most popular method to access 
spiroindoles: one possible strategy is based on the addition to alkynes. These cyclizations 
typically proceed by activation of the alkyne by a π-acidic catalyst, followed by a nucleophilic 
attack of the indole through its C-3 position.  
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In this scenario, one of the research lines of Unsworth’s group is grounded. They have 
recently published the dearomatizing spirocyclizations of indole-tethered ynones 70 (Scheme 
20: Ag+) into spirocycles 71 promoted by alkyne activation with a Ag-π-acidic catalyst via 
nucleophilic attack from the tethered indoles to form a vinyl metal intermediate I, followed by 
fast protodemetallation.[99] However, the interception of these intermediates with any external 
electrophile other than a proton was prevented by the ease with which such vinyl metal species 
undergo protodemetallation when π-acidic catalysts are used, meaning that tetrasubstituted 
alkenes are inaccessible with these methods. 
For this reason, the research group developed a one-pot protocol for dearomatizing 
spirocyclization/cross-coupling of alkyne-tethered indoles 70 (Scheme 2: Pd) in which 
palladium complexes generated in situ act as both π-acid and cross-coupling catalysts.[100] In 
this way, an efficient cascade process enables the simultaneous preparation of synthetically 
challenging quaternary spirocyclic carbons and tetrasubstituted alkenes in a single operation. 
 
Scheme 20. Dearomatizing spirocyclization of alkyne-tethered indoles. 
4.2. Radical Spirocyclisation of Indole-Tethered Ynones.10 
Due to the enormous growth of photochemistry in recent years,[101] the aim of my 
Erasmus project at York University was to develop a visible-light-mediated 
spirocyclisation protocol of indole-tethered ynones 73 in which a radical generation was 
required instead of an alkyne activation. We postulated that such ynones 73 would react 
with electrophilic radicals via regioselective addition to the alkyne group (73 → 74) 
before cyclizing onto the indole at its 3-position to form a spirocyclic radical 
intermediate (74 → 75). Radical 75 could then go on to form either spirocyclic indoline 
76 via hydrogen atom transfer (HAT), or spirocyclic indolenine 78 via single-electron 




Scheme 21. Planned reaction pathways. 
Confidence in this general idea was raised by reports of radical-based dearomative 
processes involving phenol- and anisole-tethered alkynes.[102] These studies confirm that 
electrophilic radicals can react with ynones with the desired regioselectivity, and that the 
so-formed radical species can go on to react with tethered aromatics; however, to the 
best of our knowledge, such a strategy had not been applied to indole-tethered alkynes 
prior to this report.[5]  
At the start, we examined the reaction of ynone 73a with a thiyl radical generated in situ 
from thiophenol: we reasoned that the ensuing sulfur-containing products could be relevant in 
drug discovery, in view of the presence of vinyl sulfides in bioactive compounds.[103] We 
originally chose a photoredox catalysis approach to generate the thiyl radical (Scheme 22). 
Thus, the combination of thiophenol, catalytic Ru(bpy)3(PF6)2 and irradiation with a blue LED 
lamp (λmax = 455 nM, 60 W) at r.t. under air, enabled the conversion of indole-tethered ynone 
73a into spirocyclic indolenine 78a in reasonable yield via an overall oxidative dearomative 
process (Scheme 22, entry 1) with indoline 76a as minor side-product. The latter demonstrated 
to be an intermediate on the route to indolenine: control experiments revealed that oxygen is 
required for the efficient formation of 78a (indoline 76a is the major product in the absence of 
oxygen: Scheme 22, entry 4) and more intriguingly, a mixture of both products 78a and 76a is 
formed even in the absence of any photocatalyst (Scheme 22, entry 5). In the absence of light, 





Scheme 22. Photocatalytic synthesis of spirocyclic indolenines and control reactions; all 
yields are based on comparison to an internal standard in the 1H NMR spectrum of the 
unpurified reaction mixture except for ‘a’ which is an isolated yield. CFL = compact 
fluorescent lamp. 
In Scheme 23 a restricted substrate scope of this photoredox-catalyzed radical 
spirocyclisation is reported because, instead of focusing our attention on the evaluation of 
substrate scope, we considered the unexpected discovery that spirocyclisation can be achieved 
without photocatalysis more intriguing, both from a mechanistic standpoint, and in view of the 
practical and environmental benefits of avoiding metal-based photocatalysts. 
 
Scheme 23. Substrate scope of photoredox-catalysed radical spirocyclisation. 
An additional photocatalyst-free optimization was performed with the main results 
summarized in Table S3 in the Experimental Section. An important change is that the reactions 
were performed under argon rather than air favouring the synthesis of indoline products 76/79 
rather than of indolenines 78. The optimized conditions were then tested across a range of 





Scheme 24.  Light-induced charge-transfer radical spirocyclisation. Isolated yields following 
column chromatography are given. 
Interestingly, spiroindoline 76a underwent oxidation to spiroindolenine 78a when 
exposed under light in the presence of oxygen, disclosing a new light-mediated process to 
access spiroindoles. Anyway, instead of investigating in such direction, attention turned to 
understand how the reactions operate in the absence of photocatalysis. 
 
Scheme 25 Visible light-mediated oxidation of 76a to 78a under air. 
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4.3. Mechanistic investigations. 
We reasoned that visible-light activation of one of the starting materials must play a key 
role. Control experiments were designed based on the hydrothiolation of simple alkynes 80 and 
82 reacting with n-propanethiol under blue LED irradiation at r.t., but no conversion into vinyl 
sulfides 81 and 83 was observed (Schemes 26a and 26b). The lack of hydrothiolation in these 
experiments supports the view that the indole-tethered ynone moiety 73 itself is critical to the 
observed reactivity. Indeed, when alkynes 80 and 82 were again reacted with n-propanethiol, 
but this time with the addition of catalytic (20 mol%) ynone 73k, hydrothiolation products 81 
and 83 were obtained in 54% and 80% yields, respectively, supporting the involvement of the 
ynone in initiating thiyl radical chemistry. 
 
Scheme 26.  (a) Hydrothiolation of ynone 80; (b) Hydrothiolation of alkyne 82; (c) UV-Vis 
spectroscopy studies of indole-tethered ynone 73g compared with model reaction 
components; (d) UV-Vis spectroscopy of indole-tethered ynones (73g, 73k-m) and 
propargylic alcohol 73n.   
Normally, neither ynones nor 3-substituted indoles would be expected to absorb photons 
from visible light. However, the ynones 73 used in this study tend to be yellow in colour, and 
indeed, ynone 73g was found to absorb relatively strongly around 455 nm (the λmax of the light 
source) when analyzed using UV-Vis spectroscopy (orange line, Scheme 26c). In contrast, 
model ynone 80 (light blue line), 3-substituted indole 84 (cyan line), thiophenol 85 (black line) 
and equimolar mixtures of these compounds (80+85 in grey, 80+84 in pink and 84+85 in green) 
displayed little/no absorption in the same region. The ability of the starting material to absorb 
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visible light around 455 nm appears to correlate well with the success of the radical cascade 
processes, as illustrated by the data presented in Scheme 26d. For example, alkynes 73m and 
73n, showed low absorption at 455 nm (purple and blue lines respectively) and both the 
conversion and yields for these reactions were much lower than those for the standard 
substrates. In contrast, ynones 73g, 73k, and 73l, which all reacted efficiently to form 76g, 76k 
and 76l with full conversion and in good yields, show a clear red-shift into the visible region 
(orange, red and green lines respectively).  
We postulate an intramolecular charge transfer interaction to explain the enhanced visible 
light absorption of the reactive ynone systems, via the formation of an intramolecular electron 
donor-acceptor (EDA) complex C (Scheme 27, b). The charge-transfer theory was formulated 
in 1952 by Robert Mulliken to rationalize the appearance of strong colours on bringing together 
two colourless organic compounds.[104] This theory explains how the association of an 
electronrich molecule (a donor D) and an electron-accepting molecule (an acceptor A) can 
induce the formation of a molecular aggregation in the ground state. This complex (Scheme 27, 
a)[105] has physical properties that differ from those of the separated substrates, e.g. the 
appearance of a new absorption band, the charge-transfer band (hνCT), which is associated with 
a transfer of a single electron (SET) from the donor to the acceptor. Often, the energy of this 
transition lies in the visible frequency range. The photo-physics of EDA complexes have been 
extensively studied since the 1950s,[106] while their use in chemical synthesis was exploited in 
a more intensive way only 20 years later.[107] Recently, the resurgence of visible-light-driven 
processes has motivated chemists to reinvestigate the potential of EDA complex activation for 
promoting photochemical processes.[108] Here, we expand the synthetic potential of this 
activation strategy demonstrating the possibility to form an intramolecular EDA complex and 
using its photochemical activity to initiate a radical reaction.  
Thus, a mechanism is proposed in which the formation of an EDA complex C is followed 
by visible light absorption to a photoexcited state, loosely represented as the charge transfer 
complex 24. This species may simply relax to reform the EDA complex C via back electron 
transfer, or alternatively, the open shell excited state 24 could abstract a hydrogen atom from 
the thiol, thus generating the thiyl radical needed to start a radical cascade (Scheme 27, b). At 
this point, a more typical radical chain process can operate (Scheme 27, c), which likely 
proceeds via the addition of thiyl radical to the ynone, spirocyclisation and hydrogen atom 
abstraction from thiol, thus enabling chain propagation. Quantum yield measurements (φ = 
19.8) support a chain process. 
In general, all the synthetic methods reported so far relied on the excitation of 
intermolecular EDA complexes. To our knowledge, this study offers the second demonstration 
of the potential of photon-absorbing intramolecular EDA complexes in synthetic applications 
after a 2018 report by Melchiorre and co-workers.[109] This rare radical activation mode was 











In summary, we reported a novel original approach for the benzannulation onto pyrrole 
to form 4,7-dialkyl- or diaryl-substituted mononitro- or dinitroindoles from conjugated 2,3-
dinitro-1,3-butadiene precursors with the possibility to capture in high yields a reaction 
intermediate which can independently be brought to the final expected nitroindoles much 
efficiently in different, selected experimental conditions. Very interestingly, the so assembled 
indole scaffolds bear one or two nitro groups on the benzene ring (the C5, C6 dinitro pattern 
being so far unreported in literature, indeed) while maintaining C2 and C3 free and ready for 
further manipulations: it is worth recalling that electrophilic nitration of the benzene ring of 
indoles requires, besides rather harsh conditions, that at least the most reactive C3 position be 
engaged in substitution.[2]  
In this scenario, a stereodynamic study of atropisomeric 58d has been performed, in view 
of a possible use in asymmetric catalysis: namely, the presence of hindering naphthyl moieties 
at C4 and C7 coupled with the two nitro groups at C5 and C6 provide the molecule with two 
chiral axes which generate different atropisomers due to the asymmetry of the separating indole 
moiety. To overcome some issues, the synthesis of other two atropisomeric nitroindoles (60, 
61) has been necessary for this study. All atropisomers have been separated by chiral HPLC 
determining absolute configuration and rotational barriers. The high interconversion barriers 
make them very stable at room temperature.[4] 
The nitrobenzannulation protocol has been then extended to 2-nitro-1,3-butadienes for 
the synthesis of unusual 7-aryl-6-nitroindoles which, encouraged by the wide diffusion of fused 
carbazole scaffolds among natural or synthetic biologically active compounds, have been 
proven to be valuable precursors of unusual pyrrolo[3,2-c]carbazoles 30, never reported 
before.[3] 
Finally, a new dearomative method for the synthesis of sulfur-containing spirocyclic 
indolines is described, based on the reaction of indole-tethered ynones with thiyl radicals 
generated in situ from thiols. The reactions are promoted by visible light, operate at room 
temperature under mild reaction conditions and need neither a transition metal catalyst nor 
added photocatalyst to proceed efficiently across a wide range of substrates. The reaction is 
thought to be self-initiated, with visible-light-mediated photoexcitation of an intramolecular 
EDA complex formed between the indole and ynone moieties in the starting material leading 
to the formation an open shell excited charge-transfer complex, capable of abstracting a 
hydrogen atom from the thiol and initiating radical chain propagation. To the best of our 
knowledge, this is only the second report that details the use of intramolecular EDA complexes 




Scheme 28.  
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1. General information 
Except where stated, all reagents were purchased from commercial sources and used 
without further purification. Compounds 53,[110] 54[70b] and 73[100] were prepared as previously 
reported. Except where stated, anhydrous solvents were obtained from commercial sources. 
1,2-Dichloroethane (DCE) and acetonitrile (MeCN) were degassed using argon balloon and 
stored over activated 3Å molecular sieves before use.1H NMR and 13C NMR spectra were 
recorded with a Varian Inova spectrometer (600 MHz for 1H, 150.8 MHz for 13C), a Varian 
Mercury 300 Plus spectrometer (300 MHz for 1H, 75 MHz for 13C), a JEOL ECX400 or JEOL 
ECS400 (400 MHz for 1H, 100 MHz for 13C, and 376 MHz for 19F). All spectral data was 
acquired at 295 K, unless otherwise stated; Chemical shifts are given as δ values (ppm) relative 
to the internal standard relative to the residual peak of the solvents. Coupling constants (J) are 
reported in Hertz (Hz). The multiplicity abbreviations used are: s singlet, d doublet, t triplet, q 
quartet, td triple doublet, tt triple triplet, dd double doublet, dq double quartet, m multiplet. 
Signal assignment was achieved by analysis of DEPT, COSY, NOESY, and HMQC 
experiments where required. ECD spectra were recorded on a Jasco 810 spectropolarimeter at 
+25 °C in far-UV HPLC grade acetonitrile solutions. The concentrations of the samples (about 
10-4 M) were tuned by dilution of a mother solution (1·10-3 M) to obtain a maximum 
absorbance of about 0.8 ÷ 0.9 in the UV spectrum when using a 0.2 cm path length. Infrared 
(IR) spectra were recorded on a PerkinElmer UATR 2 spectrometer, either as a compressed 
solid or neat oil. HRMS mass spectra were recorded with an Agilent ESI-QTOF 6520A mass 
spectrometer, an Agilent MSD TOF mass spectrometer, and a Bruker Daltonics Micro-Tof 
spectrometer, using electrospray ionization (ESI). Melting points were determined with a Büchi 
535 and Gallenkamp apparatus and are uncorrected. UV-Vis spectroscopy was recorded using 
Shimadzu UV-Vis Spectrophotometer UV-2600 system. Flash column chromatography was 
carried out using slurry packed Fluka silica gel (SiO2), 35–70 µm, 60 Å or Fuji Silysia 
Chromatorex Silica gel (SiO2), neutral MB100, 75-200 µm, 100 Å under a light positive 
pressure, eluting with the specified solvent system.  
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2. Experimental UV and ECD spectra of 56d and 57d. 
ECD spectra were recorded on a Jasco 810 spectropolarimeter at +25 °C in far-UV HPLC 
grade acetonitrile solutions. The concentrations of the samples (about 10-4 M) were tuned by 
dilution of a mother solution (1·10-3 M) to obtain a maximum absorbance of about 0.9÷1 in the 
UV spectrum, when using a 0.2 cm path length. The acquisition windows were from 400 to 190 
nm by step of 1 nm for 32 seconds acquisition time, with high sensitivity mode. 
 
Figure S1. Experimental UV and ECD spectra of compound 56d. 
 
 




3. Conformational analysis of compound 56d and 57d. 
As the first step for AC assignment, we performed a conformational search on compound 
56d and 57d, assuming M absolute configuration. The 1-naphthyl moieties can be positioned 
in the syn or anti dispositions, and the rings are not perfectly orthogonal to the indole. This 
situation yields four conformations, that have been optimized using DFT at the B3LYP/6-
31+G(d) level.  
 
Figure S3. Optimized geometries of 56d at the B3LYP/6-31+G(d) with M absolute 
configuration. 
 




4. Absolute configuration of compounds 56d and 57d by means of ECD method. 
The ECD spectra have been calculated for the isolated molecule in the gas phase for the 
four conformations of 56d and 57d using TD-DFT with four different functionals, to ascertain 
if different computational approaches provide different shapes of the simulated spectra (Figure 
S5 and S6).[112] Simulations were performed with the hybrid functionals BH&HLYP[113] and 
M06-2X,[114] with ωB97X-D that includes empirical dispersion,[115] and CAM-B3LYP that 
includes long-range correction using the Coulomb Attenuating Method.[116] The calculations 
employed the 6-311++G(2d,p) basis set that has proven many times to provide good accuracy 
at a moderate computational cost.[117] 
 
Figure S5. TD-DFT spectra calculated for the four conformations of 56d (M) using four 
different functionals (CAM-B3LYP, BH&HLYP, M06-2X, ωB97X-D) and the same 6-
311++G(2d,p) basis set. For each conformation the first 70 excited states were calculated, and 
the spectrum was obtained using a 0.25 eV line width at half height. 
 
Figure S6. TD-DFT spectra calculated for the four conformations of 57d (M) using four 
different functionals (CAM-B3LYP, BH&HLYP, M06-2X, ωB97X-D) and the same 6-
311++G(2d,p) basis set. For each conformation the first 70 excited states were calculated, and 
the spectrum was obtained using a 0.25 eV line width at half height. 
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The four calculated ECD spectra have different shapes, therefore the simulated spectra to 
be compared with the experimental were obtained using Boltzmann weighting with the total 
energies calculated using B3LYP (Figures S7-S8). In both cases, the ECD simulation agrees 
very well with the ECD spectrum of the first eluted atropisomer, to which the M absolute 
configuration can be assigned. 
 
Figure S7.Simulations of the experimental ECD spectrum of first eluted 56d. The calculated 
spectra for the four conformations have been mixed using the energies from B3LYP/6-
31+G(d) level. For each quarter, the black line corresponds to the experimental spectrum and 
the colored line to the TD-DFT simulations (6-311++G(2d,p) basis set). The simulated spectra 
were vertically scaled and red-shifted to get the best match with the experimental spectrum. 
All the simulations are for the M absolute configuration. 
 
Figure S8. Simulations of the experimental ECD spectrum of first eluted 57d. The calculated 
spectra for the four conformations have been mixed using the energies from B3LYP/6-
31+G(d) level. For each quarter, the black line corresponds to the experimental spectrum and 
the colored line to the TD-DFT simulations (6-311++G(2d,p) basis set). The simulated spectra 
were vertically scaled and red-shifted to get the best match with the experimental spectrum. 
All the simulations are for the M absolute configuration. 
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5. Conformational analysis of 58d, 60 and 63 
Table S1. Dihedral angles, relative energies and calculated population for compounds 58d, 
60, 63 at the B3LYP/6-31G(d) level (energies in kcal/mol). The φC4 is relative to the C5-C4-
Cα-Cq dihedral angle, the φC7 is relative to the C6-C7-Cα-Cq dihedral angle. 
Compd.  GS1    GS2   %GS1  %GS2  
 φC4  φC7   H°  φC4  φC7   H°      
63a -86  -76  0.42  -99  -107  0.00  33  67  
63d -85  108  0.00  -99  76  0.00  50  50  
60b 71  86  0.48  108  99  0.00  31  69  
60d 71  -100  0.00  109  -85  0.26  61  39  
58d(a) -71  -71  0.30  -112  -117  0.00  38  62  
58d(b) 71  -116  0.00  113  -71  0.01  51  49  
 
Table S2 Dihedral angles, relative energies and calculated population for compounds 58d, 60, 
63 at the PCM-B3LYP/6-311G(d,p) level (energies in kcal/mol). The φC4 is relative to the C5-
C4-Cα-Cq dihedral angle, the φC7 is relative to the C6-C7-Cα-Cq dihedral angle. 
Compd.  GS1    GS2   %GS1  %GS2  
 φC4  φC7   H°  φC4  φC7   H°      
63a -84  -75  0.52  -99  -102  0.00  29  71  
63d -85  101  0.20  -99  75  0.00  42  58  
60b 75  83  0.61  104  99  0.00  26  74  
60d 75  -99  0.00  104  -84  0.11  55  45  
58d(a) -78  -77  0.85  -106  -104  0.00  19  81  
58d(b) 78  -104  0.08  105  -78  0.00  47  53  
 
 
Figure S9 The two calculated transition states for naphthyl rotation of 
compound 58d. Left: TS-1 (C4-naphthyl rotation) 29.78 kcal/mol. Right: 
TS-2 (C7-naphthyl rotation) 29.76 kcal/mol    
55 
 
6. Kinetic experiments  
Figure S10. Top: kinetic experiment for the diastereomerization of 58d (letter refers to the 
substituent on position 4 and 7 of indole). The enantiopure sample of 58d was kept a +130 °C 
in C2D2Cl4, and the NMR spectra were recorded at +25 °C after a fast cooling of the sample. 
Bottom: kinetic analysis. 
 
Figure S11. HPLC of 60 after thermal equilibration at +147 °C for 24 h. Chiralpak AD-H 





Figure S12. Kinetic experiment for the conversion of 60d into 60a (letter refers order of 
elution in HPLC reported in Figure S11). The enantiopure sample of 60d was kept a +130 °C 





Figure S13. Kinetic experiment for the conversion of 63a into the syn/anti mixture. The 
enantiopure sample of 63a was kept a +130 °C in C2D2Cl4, and the NMR spectra were 




Figure S14. CSP-HPLC chromatogram of compd 62 (ChiralPak AD-H 250x4.6 mm, eluent 
n-hexane/i-PrOH 90:10, 1 mL/min).  
7. Quantum Yield Measurements 
Quantum yield of the reaction was measured based on reported methods by Yoon et al[118] 
and the calculations at λ = 455 nm ( = 0.85) by Xia et al.[119] 
The photon flux of the LED set up was measured by standard ferrioxalate actinometry.[120] 
Cuvettes were placed 1 cm from the LED light source.  
Sample calculations:  






= 2.24 × 10−7 𝑚𝑜𝑙 






= 8.83 × 10−9 einstein s−1 
Average photon flux from three experiments = 8.58 × 10−9 einstein s−1. 
Thiophenol 85 (35 µL, 0.32mmol), 73k (54.6 mg, 0.2 mmol) and DCE (2.0 mL) were charged 
into a glass cuvette equipped with a PTFE septum and a magnetic stirrer bar. The mixture was 
further sparged with argon while stirring for 5 mins. After sparging was complete, additional 
parafilm was sealed on top of the cuvette and the reaction was irradiated with a 60 W blue LED 
(1 cm away) for 15 min with stirring and cooling from a small fan to maintain ambient 
temperature.  
1H NMR yield = 64% 
Sample calculation:  






= 19.2 𝑒𝑖𝑛𝑠𝑡𝑒𝑖𝑛 𝑠−1 
 
Average quantum yield from three experiments: 19.8 𝑒𝑖𝑛𝑠𝑡𝑒𝑖𝑛 𝑠−1 
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8. X-Ray Crystallography 
Compounds 59a (CCDC 1898200), 56e (CCDC 1968434), 76a (CCDC 1945619), 76g 
(CCDC 1945660), and 76j (CCDC 1945618), were confirmed by X-ray crystallography. 


































9. Optimization details  
Table S3. Optimisation with thiophenol (PhSH). 
 
entry photocatalyst (1 mol%) solvent (0.1M) yield of 76a (%)a yield of 78a (%)a 
1 Ru(bpy)3(PF6)2 MeCN (63) (17) 
2b Ru(bpy)3(PF6)2 MeCN (8) (68) 
3b, c Ru(bpy)3(PF6)2 MeCN 4 42 
4d Ru(bpy)3(PF6)2 MeCN 0 0 
5 - MeCN (60) (9) 
6 - MeOH 48 52 
7 - DMF 0 0 
8 - DMSO 0 0 
9 - DCE (66) (10) 
10d - DCE 0 0 
11e - DCE 10 55 











Reaction conditions: 73a (0.10 mmol), PhSH (0.11 mmol), photocatalyst (1.0 mol%), degassed solvent (0.1 M), stirred under 
argon atmosphere with irradiation of blue LED light for 16 h. a 1H NMR yield determined by using CH2Br2 or 1,3,5-
trimethoxybenzene as internal standard. Isolated yields are shown in parentheses. b Sealed in air condition. c Reaction under 
CFL bulb (23W). d Reaction in the dark. e Reaction sealed under oxygen atmosphere. f with additional 5 mol% of PhSSPh. g 





10. General procedures 
General procedure for the synthesis of compounds 56a-g and 57a-g. 
To a solution of the 4,7-disubstituted-5,6-dinitro-4,7-dihydro-1H-indole 59 (0.25 mmol) 
in toluene (0.05 M), DBU (1.1 mol equiv.) was added and the reaction mixture stirred at r.t. for 
24 h. The solvent was removed under reduced pressure and the residue purified by flash 
chromatography over a silica gel column (petroleum Ether/EtOAc 8:2) to afford the mixture of 
the two mononitroindoles 56 and 57. In the cases of 56d-f and 57d-f, being the corresponding 
dihydroindole difficult to isolate, the treatment with DBU was made immediately after 
removing the TFE solvent under reduced pressure. 
General procedure for the synthesis of compounds 58a-g. 
To a solution of the 4,7-disubstituted-5,6-dinitro-4,7-dihydro-1H-indole 59 (0.25 mmol) 
in toluene (0.05 M), DDQ (2 mol equiv.) was added and the reaction mixture stirred at reflux 
for 24 h. The solvent was removed under reduced pressure and then the residue was purified by 
flash chromatography over a silica gel column (petroleum Ether/EtOAc 7:3) to afford 
compounds 58. In the cases of 58d-f, being the corresponding dihydroindole difficult to isolate, 
the treatment with DDQ was made immediately after removing the TFE solvent under reduced 
pressure. 
General procedure for the synthesis of compounds 59a-g. 
To a stirred suspension of the dinitrobutadiene 53 (0.25 mmol) in TFE (0.05 M), pyrrole 
(2 mol equiv.) was added. Temperature and time are reported in table 2. In the cases of 59d-e, 
after 24 h, a second addition of pyrrole (2 equiv.) was done. After the needed time, the solvent 
was removed under reduced pressure and then the residue purified by flash chromatography 
over a silica gel column (petroleum Ether/EtOAc 85:15). Compounds 59a-c and 59g could be 
effectively isolated, while 59d-f during silica gel chromatography convert into the mixture of 
the two mononitroindoles.  They must be submitted to the following treatments with DBU or 
DDQ without chromatographic purification. 
Synthesis of compound 60.  
To a solution of 4,7-di(naphthalen-1-yl)-5,6-dinitro-1H-indole 58d (97 mg, 0.21 mmol) 
in THF (0.07 M) at 0° C NaH (13 mg, 60% dispersion in mineral oil, 0.31 mmol) was added. 
The heterogeneous mixture was stirred at 0 °C for 1 h, then iodomethane (17 µL, 0.27 mmol) 
and the mixture was added and warmed to room temperature. After 30 min, the reaction mixture 
was quenched with saturated NH4Cl (10 mL) and extracted with ether (3x5 mL). The organic 
layers were combined, washed with brine, dried over anhydrous Na2SO4 and concentrated 
under reduced pressure to afford compound 60 (99 mg, 0.21 mmol, quantitative) as a white 
solid. The atropisomers of compound 60 were purified with semipreparative HPLC using a 
ChiralPak AD-H column (2 cmϕ x 25 cm, eluent n-hexane/i-PrOH 90:10, 20 mL/min), yielding 
the four stereoisomers. 
Synthesis of compound 61. 
A solution of 4,7-di(naphtalen-1-yl)-5,6-dinitro-1H-indole 58d (40 mg, 0.087 mmol), 4-
DMAP (16 mg, 0.13 mmol) and Boc2O (38 mg, 0.174 mmol) in THF (0.1 M), was stirred at 
room temperature until the disappearance of the starting indole monitoring the evolution of the 
62 
 
reaction by TLC (petroleum ether/ EtOAc 1:1). Then, water was added and the organic layer 
was extracted with EtOAc (3 x 5 mL), dried over Na2SO4, filtered and the solvent removed 
under reduced pressure. The crude was purified by flash chromatography (petroleum 
ether/EtOAc 7:3) obtaining a white solid (45 mg, 0.08 mmol). The diastereomeric ratio of 
compound 3a vs 3b was 3:7. This mixture was purified with semipreparative HPLC using a 
ChiralPak AD-H column (2 cmϕ x 25 cm, eluent n-hexane/i-PrOH 90:10, 20 mL/min), 
obtaining the enantiopure 61a-61d. 
 
Synthesis of compound 62. 
A solution of N-tert-butoxycarbonylindole 61 (90 mg, 0.16 mmol) and NBS (0.57 mg, 
0.32 mmol) in CH2Cl2 (0.08 M) was refluxed. After 24 h, despite the constant presence of the 
starting indole (as judged by TLC), the cooled reaction mixture was diluted with H2O (2 mL). 
The layers were separated, and the organic phase was washed (10% KOH, H2O), dried 
(Na2SO4), and concentrated. The residue was purified by flash chromatography over a silica gel 
column (petroleum ether/EtOAc 7:3), affording compound 62 (37 mg, 0.06 mmol, 36%) as a 
white solid. The atropisomers of compound 62 were purified with semipreparative HPLC using 
a ChiralPak AD-H column (2 cmϕ x 25 cm, eluent n-hexane/i-PrOH 90:10, 20 mL/min), 
obtaining the enantiopure 62a and 62d, and a mixture of 62b and 62c. Single crystals were 
obtained from the latter mixture by slow evaporation of an n-hexane/CH2Cl2 solution. 
 
Boc deprotection of 61a, 61b and 62a. 
To a stirred solution of 61a, 61b or 62a (0.02 mmol), in CH2Cl2 (0.06 M), TFA was added 
(TFA/CH2Cl2 1:1). The reaction mixture was stirred at room temperature until the 
disappearance of starting material as determined by TLC (typically 1-2 h). The mixture was 
diluted with CH2Cl2 and KOH 2M was added. The organic layer was extracted, washed with 
brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure to afford 
compound 58d(a), 58d(b) or 63a, with 92, 95 and 99% yield, respectively. 
 
General procedure for the synthesis of 7-arylsubstituted indoles (64-66 a-i) 
To a stirred suspension of the suitable nitrobutadiene 54 (0.245 mmol) in TFE (5 mL, 0.05 
M), pyrrole (4 mol equiv.) was added. Temperature and time are reported in Table 2. After the 
time necessary for the disappearance of 54 (5-7 h), the solvent was removed under reduced 
pressure and the residue purified by flash chromatography over a silica gel column (petroleum 
ether/ethyl acetate gradients). 
 
General procedure for the Cadogan reaction: synthesis of pyrrolo[3,2-c]carbazoles 68 
A 5 mL flame-dried round-bottomed flask, equipped with a condenser, was charged with 
0.11 mmol of the relevant 54 and 2.2 mL of triethylphosphite (d = 0.969 g/mL, 2.13 g, 12.8 
mmol). The resulting mixture was heated at reflux under nitrogen for 5 h, and then the excess of 
triethylphosphite was partly removed under reduced pressure (bath temperature 80 °C). The 
residue was dissolved in ethyl acetate and washed with HCl 5% solution, and water, then dried. 






General procedure for the synthesis of compounds 78a-e. 
Thiophenol (0.32 mmol, 1.6 equiv) was added to the solution of the indolyl-ynone 73 (0.2 
mmol) and Ru(bpy)3(PF)2 (1mol%) in MeCN (0.1 M). The reaction mixture was sealed under 
air and stirred for 16 h under the irradiation of 60W blue LED flood light (1–2 cm away) with 
a cooling fan. After completion of the reaction, the solution was concentrated in vacuo and 
purified by flash column chromatography. See next for photographs illustrating the reaction 
set-up. 
General procedure for the synthesis of compounds 76a-n and 79a-t. 
To a 8.0 mL screw-neck-vial (17 x 60 mm) equipped with a septa seal screw cap and 
stirrer bar was loaded thiol (0.20–0.32 mmol, 1.0–1.6 equiv) and ynone (0.2 mmol) in degassed 
DCE (2 mL, 0.1 M). The mixture was sparged with argon while stirring for 5 mins. After 
completion of sparging, the vial was additionally sealed with paraffin film and stirred for 16 h 
under irradiation of a 60 W blue LED flood light (1–2 cm away). A cooling fan was mounted 
on top of the photoreactor box to maintain ambient reaction temperature (25–30 °C). After 
completion of the reaction, the solution was concentrated in vacuo and purified by flash column 




11. Images of photochemistry experimental set-up 
1. Sparging of the reaction mixture with argon balloon 
  
2. Sealed reaction vial ready to run 
  





12. Spectroscopic data 
5-nitro-4,7-di-p-tolyl-1H-indole 56a 
 
Yellow solid, mp 199–200 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 2.45 (s, 3H), 
2.46 (3H, s), 6.49 (t, J = 2.6 Hz, 1H), 7.29-7.38 (m, 3H), 7.33 (d, J = 7.9 Hz, 2H), 7.37 (d, 
J = 7.8 Hz, 2H), 7.56 (d, J = 7.9 Hz, 2H), 7.87 (s, 1H), 8.71 (br s, 1H). 13C NMR (CDCl3, 
151 MHz): δ (ppm) 21.42, 21.51, 105.39, 118.38, 125.08, 126.96, 128.16, 128.62, 128.90, 
129.38, 129.76, 130.33, 133.61, 134.06, 135.25, 137.68, 138.59, 142.60. HRMS (ESI) m/z 
calcd. for C22H19N2O2 [M + H]+: 343.1447, found 343.1449 
4,7-bis(4-methoxyphenyl)-5-nitro-1H-indole 56b 
 
Yellow solid, mp 228–229 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 3.89 (s, 
3H), 3.90 (3H, s), 6.50 (dd, J = 3.2, 2.2 Hz, 1H), 7.03 (d, J = 8.7 Hz, 2H), 7.09 (d, J = 8.7 
Hz, 2H), 7.31 (t, J = 2.8, 1H), 7.37 (d, J = 8.7 Hz, 2H), 7.60 (d, J = 8.7 Hz, 2H), 7.83 (s, 
1H), 8.68 (br s, 1H). 13C NMR (CDCl3, 151 MHz): δ (ppm) 55.44, 55.62, 105.42, 114.16, 
115.10, 118.32, 124.77, 126.91, 128.74, 128.98, 129.19, 129.32, 129.48, 130.01, 135.28, 




Yellow solid, mp 213–214 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 6.45 (dd, 
J = 3.2, 2.1 Hz, 1H), 7.28-7.30 (m, 1H), 7.36 (dd, J = 3.3, 2.4 Hz, 1H), 7.41-7.44 (m, 3H), 
7.48 (dt, J = 7.5, 1.4 Hz, 1H), 7.52 (t, J = 7.7 Hz, 1H), 7.56 (dt, J = 7.5, 1.4 Hz, 1H), 7.67 
(t, J = 1.6 Hz, 1H), 7.94 (s, 1H), 8.75 (br s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 
105.39, 118.66, 124.16, 126.54, 126.94, 127.67, 128.24, 128.36, 128.74, 128.95, 129.09, 
129.93, 131.05, 134.46, 135.07, 135.63, 138.35, 138.55, 141.99 (two carbons are 
accidentally isochronous). HRMS (ESI) m/z calcd. for C20H13Cl2N2O2 [M + H]+: 
383.0354, found 383.0356. 
4,7-di(1-naphthyl)-5-nitro-1H-indole 56d 
 
Yellow solid, mp 267–268 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 6.16 (td, J 
= 3.4, 2.2 Hz,1H), 7.14 (t, J = 2.7 Hz,1H), 7.35 – 7.78 (m,10H), 7.92 – 7.98 (m, 2H), 7.98 
– 8.05 (m, 2H), 8.19 (s, 1H), 8.23 (br s, 1H) (two atropisomers are present). 13C NMR 
(CDCl3, 151 MHz): δ (ppm) 105.51, 120.21, 124.13, 125.46, 125.55, 125.57, 125.94, 
126.09, 126.31, 126.38, 126.46, 126.63, 127.10, 128.07, 128.40, 128.59, 128.90, 129.08, 
129.39, 129.45, 131.40, 131.91, 133.75, 134.11, 134.81, 136.53, 136.56, 142.82. HRMS 
(ESI) m/z calcd. for C28H19N2O2 [M + H]+: 415.1447, found 415.1445. 
5-nitro-4,7-di(2-thienyl)-1H-indole 56e 
 
Yellow solid, mp 170–171 °C (ethanol). 1H NMR (CDCl3, 400 MHz): δ (ppm) 6.70 (dd, 
J = 3.3, 2.2 Hz, 1H), 7.11 –7.19 (m, 2H), 7.24 (dd, J = 5.1, 3.6 Hz, 1H), 7.39 (t, J = 2.7 
Hz, 1H), 7.45 (dd, J = 3.6, 1.1 Hz, 1H), 7.46–7.50 (m, 2H), 7.94 (s, 1H), 8.98 (br s, 1H). 
13C NMR (CDCl3, 101 MHz): δ (ppm) 105.57, 117.85, 118.65, 122.01, 126.03, 126.38, 
126.87, 127.24, 127.45, 127.72, 128.36, 129.68, 134.10, 135.68, 138.17, 143.27. HRMS 






Yellow solid, mp 245–246 °C (ethanol). 1H NMR (Acetone-d6, 300 MHz): δ (ppm) 2.55 
(s, 3H), 2.76 (s, 3H), 6.82 (dd, J = 3.2, 2.0 Hz, 1H), 7.52 (t, J = 2.9 Hz, 1H), 7.67 (s, 1H), 
10.83 (br s, 1H). 13C NMR (Acetone-d6, 75 MHz): δ (ppm) 15.58, 15.72, 103.30, 115.66, 
118.33, 119.40, 125.22, 126.97, 128.39, 137.14. HRMS (ESI) m/z calcd. for C10H11N2O2 
[M + H]+: 191.0821, found 191.0823. 
4,7-diethyl-5-nitro-1H-indole 56g 
 
Yellow solid, mp 129–130 °C (ethanol). 1H NMR (300 MHz): δ (ppm) 1.40 (t, J = 7.6 and 
7.4 Hz6H, two part. overlapped), 2.89 (qd, J = 7.6, 0.7 Hz, 2H), 3.21 (q, J = 7.4 Hz, 2H), 
6.78 (dd, J = 3.3, 2.1 Hz, 1H), 7.35 (dd, J = 3.1, 2.7 Hz, 1H), 7.74 (s, 1H), 8.50 (br s, 1H). 
13C NMR (CDCl3, 75 MHz): δ (ppm) 13.34, 14.75, 23.50, 23.67, 103.95, 117.67, 124.80, 
125.72, 127.60, 132.14, 136.34, 141.97. HRMS (ESI) m/z calcd. for C12H15N2O2 [M + 
H]+: 219.1134, found 219.1133 
6-nitro-4,7-di-p-tolyl-1H-indole 57a 
 
Yellow solid, mp 226–227 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 2.45 (s, 
3H), 2.47 (s, 3H), 6.83 (dd, J = 3.0, 2.2 Hz, 1H), 7.28 – 7.35 (m, 6H), 7.39 (t, J = 2.8 Hz, 
1H), 7.65 (d, J = 8.0 Hz, 2H), 7.92 (s, 1H), 8.37 (br s, 1H). 13C NMR (CDCl3, 151 MHz): 
δ (ppm) 21.39, 21.48, 103.49, 116.04, 120.80, 128.55, 128.65, 129.31, 129.34, 129.67, 
130.05, 131.27, 133.84, 135.22, 136.33, 137.95, 138.41, 143.13. 1HRMS (ESI) m/z calcd. 
for C22H19N2O2 [M + H]+: 343.1447, found 343.1446 
4,7-bis(4-methoxyphenyl)-6-nitro-1H-indole 57b 
 
Yellow solid, mp 183–184 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 3.88 (s, 
3H), 3.90 (s, 3H), 6.82 (dd, J = 3.1, 2.2 Hz, 1H), 7.02 – 7.10 (m, 4H), 7.36 (d, J = 8.6 Hz, 
2H), 7.40 (t, J = 2.8 Hz, 1H), 7.68 (d, J = 8.7 Hz, 2H), 7.87 (s, 1H), 8.38 (br s, 1H). 13C 
NMR (CDCl3, 151 MHz): δ (ppm) 55.50, 55.54, 103.51, 114.41, 114.84, 115.86, 120.23, 
126.22, 129.20, 129.23, 129.90, 130.00, 131.71, 133.53, 135.40, 143.32, 159.64, 159.80. 
HRMS (ESI) m/z calcd. for C22H19N2O4 [M + H]+: 375.1345, found 375.1347. 
4,7-bis(3-chlorophenyl)-6-nitro-1H-indole 57c 
 
Yellow solid, mp 139–140 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 6.82 (dd, 
J = 3.2, 2.1 Hz, 1H), 7.29-7.32 (m, 1H), 7.43-7.44 (m, 2H), 7.46-7.49 (m, 4H), 7.61 (dt, J 
= 7.5, 1.5 Hz, 1H), 7.72 (t, J = 1.8 Hz, 1H), 7.96 (s, 1H), 8.40 (br s, 1H). 13C NMR (CDCl3, 
151 MHz): δ (ppm) 103.37, 116.37, 120.08, 126.97, 127.02, 128.33, 128.75, 128.81, 
128.91, 129.58, 130.27, 130.30, 130.66, 132.91, 134.91, 135.01, 135.23, 136.08, 140.76, 
142.60. HRMS (ESI) m/z calcd. for C20H13Cl2N2O2 [M + H]+: 383.0354, found 383.0355. 
4,7-di(1-naphthyl)-6-nitro-1H-indole 57d 
 
Yellow solid, mp 263–264 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 6.34 (s, 
1H), 7.24 (t, J = 2.8 Hz, 1H), 7.35 – 8.05 (m, 14H), 8.09 (s, 1H), 8.16 (br s, 1H) (two 
atropisomers are present). 13C NMR (CDCl3, 151 MHz): δ (ppm) 103.74, 118.02, 119.50, 
124.93, 125.01, 125.43, 125.69, 126.05, 126.21, 126.44, 126.55, 126.88, 127.64, 128.40, 
128.53, 128.62, 128.97, 129.39, 131.38, 131.51, 131.61, 131.93, 133.04, 133.84, 133.86, 






Yellow solid, mp 190-191 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 7.07 (dd, J 
= 3.2, 2.2 Hz, 1H), 7.18 – 7.22 (m, 3H), 7.46 (dd, J = 5.1, 1.0 Hz, 1H), 7.48 (t, J = 2.8 Hz, 
1H), 7.50 – 7.56 (m, 2H), 8.02 (s, 1H), 8.64 (br s, 1H). 13C NMR (CDCl3, 151 MHz): δ 
(ppm) 103.92, 113.19, 115.59, 126.31, 126.40, 127.61, 127.75, 127.95, 128.07, 128.17, 
128.28, 129.65, 133.34, 135.92, 141.13, 144.01. HRMS (ESI) m/z calcd. for 
C16H11N2O2S2 [M + H]+: 327.0262, found 327.0264. 
4,7-dimethyl-6-nitro-1H-indole 57f 
 
Yellow solid, mp 160–161 °C (ethanol). 1H NMR (CDCl3, 300 MHz): δ (ppm) 2.56 (s, 
3H), 2.74 (s, 3H), 6.64 (dd, J = 3.2, 2.1 Hz, 1H), 7.46 (t, J = 3.2 Hz, 1H), 7.66 (s, 1H), 
8.58 (br s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 14.41, 18.51, 102.74, 116.15, 116.93, 
128.37, 128.42, 131.15, 134.81 (two carbons are accidentally isochronous). HRMS (ESI) 
m/z calcd. for C10H11N2O2 [M + H]+: 191.0821, found 191.0822. 
4,7-diethyl-6-nitro-1H-indole 57g 
 
Yellow solid, mp 120–122 °C (ethanol). 1H NMR (CDCl3, 300 MHz): δ (ppm) 1.39 (t, J 
= 7.6 and 7.5 Hz, 6H, two part. overlapped), 2.94 (q, J = 7.6 Hz, 2H), 3.15 (q, J = 7.5 Hz, 
2H), 6.67 (dd, J = 3.2, 2.0 Hz, 1H), 7.45 (dd, J = 3.2, 2.6 Hz, 1H), 7.65 (s, 1H), 8.53 (br 
s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 14.07, 14.26, 21.57, 25.81, 102.31, 102.41, 
115.25, 121.80, 128.02, 130.42, 134.15, 134.62. HRMS (ESI) m/z calcd. for C12H15N2O2 




Yellow solid, mp 292–293 °C (ethanol). 1H NMR (CDCl3, 600 MHz): δ (ppm) 2.44 (s, 
3H), 2.45 (s, 3H), 6.57 (t, J = 2.3 Hz, 1H), 7.31 (d, J = 8.1 Hz, 2H), 7.32-7.43 (m, 6H), 
7.43 (t, J = 2.3 Hz, 1H), 8.57 (br s, 1H). 13C NMR (CDCl3, 151 MHz): δ (ppm) 21.52 (two 
isochronous carbons), 105.72, 120.26, 128.43, 128.48, 128.70, 128.74, 129.03, 129.74, 
129.93, 130.46, 130.99, 133.63, 137.79, 138.76, 139.12, 139.97. HRMS (ESI) m/z calcd. 
for C22H18N3O4 [M + H]+: 388.1297, found 388.1298. 
4,7-bis(4-methoxyphenyl)-5,6-dinitro-1H-indole 58b 
 
Yellow solid, mp 253–254 °C (ethanol). 1H NMR (Acetone-d6, 300 MHz): δ (ppm) 3.90 
(s, 6H), 6.57 (t, J = 3.2 Hz, 1H), 7.09-7.15 (m, 4H), 7.43-7.50 (m, 4H), 7.75 (t, J = 3.2 Hz, 
1H), 11.06 (br s, 1H). 13C NMR (Acetone-d6, 75 MHz): δ (ppm) 55.71, 55.76, 105.22, 
115.20, 115.52, 121.10, 124.25, 127.00, 128.73, 129.41, 130.80, 131.25, 132.95, 134.63, 
137.82, 139.22, 161.19, 161.48. HRMS (ESI) m/z calcd. for C22H18N3O6 [M + H]+: 
420.1196, found 420.1198. 
4,7-bis(3-chlorophenyl)-5,6-dinitro-1H-indole 58c 
 
Yellow solid, mp 207–208 °C (ethanol). 1H NMR (CDCl3, 300 MHz): δ (ppm) 6.55 (dd, 
J = 3.3, 2.1 Hz, 1H), 7.32-7.39 (m, 2H), 7.42-7.56 (m, 7H), 8.65 (br s, 1H). 13C NMR 
(CDCl3, 75 MHz): δ (ppm) 105.60, 119.30, 126.96, 127.13, 127.89, 128.54, 128.92, 
128.93, 129.54, 130.27, 130.39, 130.97, 131.13, 132.87, 133.26, 134.97, 135.35, 135.74, 






1H-NMR (600 MHz, CD3CN, 1.96 ppm): δ 6.11 (d, J = 3.2 Hz, 1H), 7.42 (d, J = 3.2 Hz, 
1H), 7.497.75 (m, 10H), 8.09 (d, J = 8.0 Hz, 1H), 8.12 (d, J = 8.0 Hz, 2H), 8.18 (d, J = 
8.0 Hz, 1H), 9.84 (br s, 1H). 13C NMR (150.8 MHz, CD3CN, 118.26 ppm): δ 105.6, 121.1, 
125.9, 126.4, 126.5, 126.8, 127.4, 127.5, 127.6, 127.7, 128.1, 128.3, 129.0, 129.5, 129.6, 
130.2, 130.3, 130.4, 130.9, 132.7, 132.8, 132.9, 133.1, 134.6, 134.9, 135.1, 138.9, 139.9. 




1H-NMR (600 MHz, CD3CN, 1.96 ppm): δ 6.18 (d, J = 3.2 Hz, 1H), 7.45 (d, J = 3.2 Hz, 
1H), 7.497.58 (m, 2H), 7.60-7.76 (m, 8H), 8.08 (d, J = 8.3 Hz, 1H), 8.115 (d, J = 8.1 Hz, 
1H), 8.12 (d, J = 8.3 Hz, 1H), 8.18 (d, J = 8.1 Hz, 1H), 9.90 (br s, 1H). 13C NMR (150.8 
MHz, CD3CN, 118.26 ppm): δ 105.6, 121.0, 125.8, 126.2, 126.5, 126.7, 127.5, 127.7, 
127.8, 128.16, 128.2, 128.87, 128.9, 129.5, 129.6, 129.8, 130.3, 130.5, 130.9, 132.3, 132.5, 
132.6, 133.2, 134.6, 134.9, 135.2, 138.8, 139.8. HRMS (ESI-QTOF) m/z calcd. for 




Yellow solid, mp 251–252 °C (ethanol). 1H NMR (Acetone-d6, 300 MHz): δ (ppm) 6.81 
(m, 1H), 7.26-7.30 (m, 2H), 7.35 (dd, J = 3.6, 1.2 Hz, 1H), 7.43 (dd, J = 3.6, 1.2 Hz, 1H), 
7.79-7.86 (m, 2H), 11.33 (br s, 1H). 13C NMR (Acetone-d6, 75 MHz): δ (ppm) 104.56, 
109.99, 113.90, 121.37, 127.77, 128.00, 128.54, 128.87, 129.00, 129.15, 129.68, 130.16, 
132.74, 132.86, 132.91, 133.99. HRMS (ESI) m/z calcd. for C16H10N3O4S2 [M + H]+ 




Yellow solid, mp 228–229 °C (ethanol). 1H NMR (CDCl3, 300 MHz): δ (ppm) 2.58 (s, 
3H), 2.62 (s, 3H), 6.79 (dd, J = 3.3, 2.0 Hz, 1H), 7.53 (dd, J = 3.3, 2.6 Hz, 1H), 8.75 (br 
s, 1H). 13C NMR (Acetone-d6, 75 MHz): δ (ppm) 12.17, 14.08, 103.90, 115.89, 123.78, 
128.08, 130.77, 133.61, 137.69, 139.04. HRMS (ESI) m/z calcd. for C10H10N3O4 [M + 
H]+: 236.0666, found 236.0663. 
4,7-diethyl-5,6-dinitro-1H-indole (58g) 
 
Yellow solid, mp 182–183 °C (ethanol). 1H NMR (CDCl3, 300 MHz): δ (ppm) 1.39 (t, J 
= 7.7 Hz, 6H, two part. overlapped), 2.96 (q, J = 7.6 Hz, 4H, two part. overlapped), 6.80 
(dd, J = 3.3, 2.1 Hz, 1H), 7.53 (dd, J = 3.2, 2.7 Hz, 1H), 8.76 (br s, 1H). 13C NMR 
(CDCl3,75 MHz): δ (ppm) 14.18, 14.83, 21.21, 23.15, 104.41, 120.88, 127.65, 129.06, 
130.33, 132.95, 137.81, 139.06. HRMS (ESI) m/z calcd. for C12H14N3O4 [M + H]+: 





(4S,7S)- and (4R,7R)-5,6-dinitro-4,7-di-p-tolyl-4,7-dihydro-1H-indole (59a) 
 
Yellow solid, mp 248–249 °C (petroleum ether/dichloromethane). 1H NMR (Acetone-d6, 
300 MHz): δ (ppm) 2.29 (s, 3H), 2.30 (s, 3H), 5.68 (A of AB system, J = 7.2 Hz, 1H), 
5.74 (t, J = 2.7 Hz, 1H), 5.82 (B of AB system, J = 7.2 Hz, 1H), 6.76 (td, J = 2.8, 0.6 Hz, 
1H), 7.12 – 7.23 (m, 8H), 9.93 (br s, 1H). 13C NMR (Acetone-d6, 75 MHz): δ (ppm) 21.06 
(two isochronous carbons), 43.49, 44.44, 106.42, 116.24, 121.41, 123.33, 129.23, 129.38, 
130.37, 130.54, 134.70, 136.59, 138.70, 139.25, 147.92, 149.69. HRMS (ESI) m/z calcd. 
for C22H20N3O4 [M + H]+: 390.1454, found 390.1458. 
(4S,7S)- and (4R,7R)-4,7-bis(4-methoxyphenyl)-5,6-dinitro-4,7-dihydro-1H-indole (59b) 
 
Yellow solid, mp 189–190 °C (petroleum ether/dichloromethane). 1H NMR (CDCl3, 300 
MHz,): δ (ppm) 3.78 (s, 6H, two part. overlapped), 5.51 (A of AB system, J = 7.2 Hz, 
1H), 5.57 (B of AB system, J = 7.2 Hz, 1H), 5.84 (t, J 2.7 Hz, 1H), 6.70 (t, J = 2.7 Hz, 
1H), 6.82-6.89 (m, 4H), 7.09-7.15 (m, 4H), 7.71 (br s, 1H). 13C NMR (CDCl3, 75 MHz): 
δ (ppm) 42.18, 43.19, 55.24, 55.32, 106.42, 114.48, 114.84, 116.02, 120.48, 122.47, 
127.37, 129.41, 129.50, 129.61, 145.62, 148.30, 159.54, 160.05. HRMS (ESI) m/z calcd. 
for C22H20N3O6 [M + H]+: 422.1352, found 422.1356. 
(4S,7S)- and (4R,7R)-4,7-bis(3-chlorophenyl)-5,6-dinitro-4,7-dihydro-1H-indole (59c) 
 
Yellow solid, mp 113–114 °C (petroleum ether/dichloromethane). 1H NMR (CDCl3, 300 
MHz): δ (ppm) 5.56 (A of AB system, J = 7.2 Hz, 1H), 5.64 (B of AB system, J = 7.2 Hz, 
1H), 5.85 (t, J = 2.7 Hz, 1H), 6.75 (t, J = 2.8 Hz, 1H) 7.09-7.13 (m, 2H), 7.17-7.18 (m, 
2H), 7.26-7.33 (m, 4H), 7.75 (br s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 42.55, 
43.59, 106.57, 115.43, 121.23, 121.51, 126.58, 126.61, 128.43, 128.50, 128.90, 129.56, 
130.41, 130.82, 135.04, 135.50, 137.38, 139.30, 145.49, 148.17. HRMS (ESI) m/z calcd. 
for C20H14Cl2N3O4 [M + H]+: 430.0361, found 430.0365. 
(4S,7S)- and (4R,7R)-4,7-diethyl-5,6-dinitro-4,7-dihydro-1H-indole (59g) 
 
Yellow solid, mp 117–119 °C (petroleum ether/dichloromethane). 1H NMR (CDCl3, 300 
MHz): δ (ppm) 0.72 (t, J = 7.4 Hz, 6H, two part. overlapped), 1.68 – 1.88 (m, 4H), 4.41 
(A of app ABX2, 5J = 7.2, 3J = 4.0 Hz, 1H), 4.52 (B of app ABX2, 5J = 7.2, 3J = 4.1 Hz, 
1H), 6.05 (t, J = 2.6 Hz, 1H), 6.83 (t, J = 2.7 Hz, 1H), 7.98 (br s, 1H). 13C NMR (CDCl3, 
75 MHz): δ (ppm) 8.21, 8.24, 24.64, 25.11, 36.75, 37.69, 105.60, 115.04, 119.63, 122.00, 




1H NMR (600 MHz, CDCl3, 7.26 ppm): δ 2.87 (s, 3H), 6.10 (d, J = 3.2 Hz, 1H), 7.07 
(d, J = 3.2 Hz, 1H), 7.44 (ddd, J = 8.4, 6.9, 1.0 Hz, 1H), 7.50-7.65 (m, 9H), 7.97 (d, J = 
8.5 Hz, 2H), 8.00 (d, J = 8.5 Hz, 1H), 8.04 (d, J = 8.5 Hz, 1H). 13C NMR (150.8 MHz, 
CDCl3, 77.36 ppm): δ 36.1, 104.6, 119.7, 125.3, 125.7, 126.0, 126.1, 126.7, 127.03, 
127.06, 127.8, 128.8, 128.9, 129.0, 129.3, 129.8, 130.6, 130.7, 131.9, 132.1, 133.0, 
133.4, 133.9, 134.0, 136.9, 137.7, 140.7. HRMS (ESI-QTOF) calcd. for C29H20N3O4 [M 







1H NMR (600 MHz, CD3CN, 1.96 ppm): δ 2.9 (s, 3H), 6.14 (d, J = 3.2 Hz, 1H), 7.35 
(d, J = 3.2 Hz, 1H), 7.52 (ddd, J = 8.5, 6.6, 1.1 Hz, 1H), 7.57-7.73 (m, 9H), 8.08 (d, J 
= 8.3 Hz, 1H), 8.10 (d, J = 8.3 Hz, 1H), 8.12 (d, J = 8.3 Hz, 1H), 8.17 (d, J = 8.3 Hz, 
1H). 13C NMR (150.8 MHz, CD3CN, 118.26 ppm): δ 36.3, 104.5, 120.5, 126.0, 126.5, 
126.6, 127.5, 127.7, 127.8, 128.3, 128.4, 129.2, 129.4, 129.5, 129.8, 130.0, 130.2, 
131.0, 131.6, 132.3, 132.4, 134.0, 134.0, 134.1, 134.6, 137.8, 139.1, 140.9. HRMS 
(ESI-QTOF) calcd. for C29H20N3O4 [M + H]+: 474.1448, found 470.1450.  
 
tert-Butyl 4,7-di(naphthalen-1-yl)-5,6-dinitro-1H-indole-1-carboxylate 61a/61c 
 
1H NMR (600 MHz, CD3CN, 1.96 ppm): δ 1.00 (s, 9H), 6.16 (d, J = 3.8 Hz, 1H), 7.47-
7.51 (m, 2H), 7.53 (ddd, J = 8.5, 6.7, 1.2 Hz, 1H), 7.58 (ddd, J = 8, 4.95, 2.9 Hz, 1H), 
7.61-7.66 (m, 5H), 7.69 (dd, J = 8.1, 7.1 Hz, 1H), 7.75 (d, J = 3.6 Hz, 1H), 8.04 (d, J = 
8.2 Hz, 1H), 8.05 (dd, J = 7.4, 1.8 Hz, 1H), 8.09 (d, J = 8.3 Hz, 1H), 8.14 (d, J = 8.3 
Hz, 1H). 13C NMR (150.8 MHz, CD3CN, 118.26 ppm): δ 27.1, 86.2, 107.4, 122.7, 
125.3, 126.2, 126.5, 126.6, 127.3, 127.4, 127.6, 127.8, 127.9, 128.0, 128.8, 129.5, 
129.6, 130.2, 130.7, 131.7, 132.2, 132.6, 132.7, 133.6, 134.2, 134.3, 134.5, 135.1, 
140.2, 142.5, 147.6. HRMS (ESI-QTOF) calcd. for C33H26N3O6 [M + H]+: 560.1816, 
found 560.1821. 
 
tert-Butyl 4,7-di(naphthalen-1-yl)-5,6-dinitro-1H-indole-1-carboxylate 61b/61d 
 
1H NMR (600 MHz, CD3CN, 1.96 ppm): δ 1.05 (s, 9H), 6.23 (d, J = 3.7 Hz, 1H), 7.49-
7.68 (m, 9H), 7.70 (t, J = 7.7 Hz, 1H), 7.78 (d, J = 3.7 Hz, 1H), 8.04 (d, J = 8.3 Hz, 
1H), 8.05 (d, J = 8.3 Hz, 1H), 8.09 (d, J = 8.3 Hz, 1H), 8.15 (d, J = 8.3 Hz, 1H). 13C 
NMR (150.8 MHz, CD3CN, 118.26 ppm): δ 27.2, 86.3, 107.4, 122.8, 125.7, 126.1, 
126.4, 126.4, 127.4, 127.6, 127.7, 127.8, 128.0, 128.6, 128.7, 129.5, 129.6, 130.2, 
130.7, 131.5, 132.0, 132.3, 132.5, 133.8, 134.4, 134.5, 134.6, 135.3, 140.2, 142.2, 
147.6. HRMS (ESI-QTOF) calcd. for C33H26N3O6 [M + H]+: 560.1816, found 
560.1817.  
 
tert-Butyl 3-bromo-4,7-di(naphthalen-1-yl)-5,6-dinitro-1H-indole-1-carboxylate 62a/62c 
 
1H NMR (600 MHz, CD3CN, 1.96 ppm): δ 0.98 (s, 9H), 7.47-7.67 (m, 10H), 7.92 (s, 
1H), 8.04 (d, J = 8.3 Hz, 1H), 8.05-8.08 (m, 2H), 8.14 (d, J = 8.0 Hz, 1H). 13C NMR 
(150.8 MHz, CD3CN, 118.26 ppm): δ 27.0, 86.9, 95.7, 123.2, 125.2, 125.9, 126.5, 
126.7, 127.4, 127.8, 127.9, 128.6, 128.9, 129.2, 129.4, 129.5, 129.7, 130.4, 130.9, 
131.7, 132.3, 133.6, 133.9, 134.4, 134.8, 135.5, 141.1, 142.4, 146.6. HRMS (ESI-
QTOF) calcd. for C33H25N3O6Br [M + H]+: 638.0921, found 638.0926.  
 
tert-Butyl 3-bromo-4,7-di(naphthalen-1-yl)-5,6-dinitro-1H-indole-1-carboxylate 62b/62d 
 
1H NMR (600 MHz, CD3CN, 1.96 ppm): δ 1.06 (s, 9H), 7.51-7.67 (m, 9H), 7.74 (d, J 
= 8.4 Hz, 1H), 7.95 (s, 1H), 8.02-8.08 (m, 3H), 8.14 (d, J = 8.2 Hz, 1H). 13C NMR 
(150.8 MHz, CD3CN, 118.26 ppm): δ 27.1, 87.1, 95.7, 123.3, 125.6, 125.9, 126.5, 
126.6, 127.4, 127.5, 127.8, 127.8, 127.9, 128.5, 129.2, 129.3, 129.5, 129.5, 129.7, 
130.4, 130.9, 131.6, 132.1, 133.9, 134.0, 134.4, 134.6, 135.8, 141.2, 142.0, 146.7. 








1H NMR (600 MHz, CD3CN, 1.96 ppm): δ 7.50-7.60 (m, 10H), 7.72 (dd, J = 8.1, 7.0 
Hz, 1H), 8.06 (d, J = 8.2 Hz, 1H), 8.12 (d, J = 8.2 Hz, 2H), 8.19 (d, J = 8.2 Hz, 1H), 
10.0 (br s, 1H). 13C NMR (150.8 MHz, CD3CN, 118.26 ppm): δ 92.9, 121.9, 125.7, 
125.9, 126.0, 126.7, 126.8, 127.3, 127.6, 127.7, 128.2, 128.3, 128.5, 128.8, 129.2, 
129.4, 129.6, 130.52, 130.54, 131.1, 132.8, 133.8, 134.0, 134.8, 134.9, 135.0, 139.8, 






1H NMR (600 MHz, CD3CN, 1.96 ppm): δ 7.51-7.59 (m, 3H), 7.59-7.68 (m, 6H), 7.70 
(dd, J = 7.2, 1.0 Hz, 1H), 7.74 (dd, J = 8.0, 7.0 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 8.12 
(t, J = 8.0 Hz, 2H), 8.19 (d, J = 8.0 Hz, 1H), 10.19 (br s, 1H). 13C NMR (150.8 MHz, 
CD3CN, 118.26 ppm): δ 92.9, 121.8, 125.7, 125.7, 125.9, 126.7, 126.8, 127.3, 127.7, 
127.7, 128.3, 128.7, 129.0, 129.1, 129.3, 129.5, 129.6, 130.1, 130.5, 131.1, 132.4, 
134.0, 134.1, 134.3, 134.9, 135.1, 139.7. HRMS(ESI-QTOF) calcd. for C28H17N3O4Br 






Waxy solid. 1H NMR (CDCl3, 300 MHz): δ (ppm) 2.43 (s, 3H), 6.67 (dd, J = 3.2, 2.1 
Hz, 1H), 7.29 (AA’BB’, 4H), 7.37 (dd, J = 3.2, 2.6 Hz, 1H), 7.66 (d, J = 8.7 Hz, 1H), 
7.85 (d, J = 8.7 Hz, 1H), 8.28 (br s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 21.30, 
103.55, 116.61, 119.59, 122.02, 128.25, 129.31, 129.84, 130.99, 131.14, 134.57, 






Orange oil. 1H NMR (CDCl3, 300 MHz): δ (ppm) 6.68 (dd, J = 3.2, 2.1 Hz, 1H), 7.35-
7.42 (m, 3H), 7.43-7.56 (m, 3H), 7.67 (d, J = 8.7 Hz, 1H), 7.87 (d, J = 8.7 Hz, 1H), 8.30 
(br s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 103.62, 116.64, 119.80, 121.99, 128.38, 
128.43, 129.13, 129.41, 131.13, 134.32, 134.51, 142.48. HRMS (ESI) m/z calcd. for 






Yellow solid, mp 175-177 °C (taken-up with petroleum ether/DCM). 1H NMR (CDCl3, 
300 MHz): δ (ppm) 3.87 (s, 3H), 6.67 (dd, J = 3.2, 2.1 Hz, 1H), 7.03 (half AA’BB’, 2H), 
7.32 (half AA’BB’, 2H), 7.37 (dd, J = 3.2, 2.6 Hz, 1H), 7.65 (d, J = 8.7 Hz, 1H), 7.82 (d, 
J = 8.7 Hz, 1H), 8.32 (br s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 55.33, 103.62, 
114.64, 116.65, 119.57, 121.67, 126.10, 129.23, 129.70, 130.93, 134.77, 142.77, 159.62. 





Yellowish solid, mp 122-125 °C (taken-up with petroleum ether/DCM). 1H NMR 
(CDCl3, 300 MHz): δ (ppm) 6.70 (dd, J = 3.2, 2.0 Hz, 1H), 7.28 (td, 1H), 7.40-7.50 m(, 
4H), 7.70 (d, J = 8.7 Hz, 1H), 7.91 (d, J = 8.7 Hz, 1H), 8.23 (br s, 1H). 13C NMR (CDCl3, 
75 MHz): δ (ppm) 103.85, 116.75, 120.32, 120.51, 126.82, 128.55, 128.63, 129.67, 
130.45, 131.42, 134.34, 135.02, 136.23, 142.26. HRMS (ESI) m/z calcd. for 







Yellow solid, mp 110-113 °C (taken-up with petroleum ether/DCM). 1H NMR (CDCl3, 
300 MHz): δ (ppm) 6.69 (t, J = 2.5 Hz, 1H), 7.33 (d, J = 8.4 Hz, 2H), 7.40 (t, J = 2.9 Hz, 
1H), 7.50 (d, J = 8.3 Hz, 2H), 7.70 (d, J = 8.7 Hz, 1H), 7.89 (d, J = 8.7 Hz, 1H), 8.23 (s, 
1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 103.79, 116.77, 120.19, 120.78, 129.44, 
129.63, 129.92, 131.34, 132.81, 134.42, 134.55, 142.35. HRMS (ESI) m/z calcd. for 




Yellow solid, mp 248-249 °C (taken-up with petroleum ether/DCM). 1H NMR (CDCl3, 
300 MHz): δ (ppm) 3.17 (s, 3H), 6.72 (dd, J = 3.1, 2.0 Hz, 1H), 7.44 (dd, J = 3.2, 2.6 Hz, 
1H), 7.62 (half AA’BB’, J = 8.5 Hz, 2H), 7.75 (dd, J = 8.7, 0.8 Hz, 1H), 7.98 (d, J = 8.7 
Hz, 1H), 8.10 (half AA’BB’, J = 8.4 Hz, 2H), 8.24 (br s, 1H). 13C NMR (CDCl3, 75 
MHz): δ (ppm) 44.53, 104.01, 116.86, 120.13, 120.83, 128.23, 129.75, 130.17, 131.84, 
134.14, 140.46, 140.88, 141.96. HRMS (ESI) m/z calcd. for C15H13N2O4S [M + H]+: 




Yellow solid, mp 143-145 °C (taken-up with petroleum ether/DCM).1H NMR (CDCl3, 
300 MHz): δ (ppm) 6.75 (dd, J = 3.3, 2.1 Hz, 1H), 7.46 (dd, J = 3.3, 2.7 Hz, 1H), 7.78 
(dd, J = 8.8, 0.8 Hz, 1H), 7.87 (s2H), 7.99-8.05 (m, 2H), 8.08 (br s, 1H). 13C NMR 
(CDCl3, 75 MHz): δ (ppm) 104.28, 117.05, 118.89, 121.24, 122.45 (app quint, J = 3.72 
Hz), 123.07 (q, J = 273.16 Hz), 129.06 (app d, J = 3.74 Hz), 130.34, 132.07, 132.58 (q, 
J = 33.30 Hz), 134.28, 137.13, 141.95. HRMS(ESI) m/z calcd. for C16H9F6N2O2 [M + 




Orange oil. 1H NMR (CDCl3, 300 MHz): δ (ppm) 6.70 (dd, J = 3.2, 2.0 Hz, 1H), 7.30 (t, 
1H), 7.34 (app.d , 2H), 7.43-7.54 (m, 3H), 7.58 (dd, J = 8.3, 7.0 Hz, 1H), 7.79 (dd, J = 
8.7, 0.8 Hz, 1H), 7.93-7.99 (m, 2H), 8.05 (d, J = 8.7 Hz, 1H). 13C NMR (CDCl3, 75 
MHz): δ (ppm) 103.53, 116.77, 120.20, 120.42, 124.86, 125.65, 126.33, 126.37, 126.82, 
128.58, 128.87, 129.55, 131.29, 131.42, 132.01, 133.80, 135.05, 143.25. HRMS (ESI) 







Yellow solid, mp 112-114 °C (taken-up with petroleum ether/DCM). 1H NMR (CDCl3, 
300 MHz): δ (ppm) 6.68 (dd, J = 3.2, 2.1 Hz, 1H), 7.14-7.23 (m, 2H), 7.42 (t, J = 2.9 Hz, 
1H), 7.53 (dd, J = 5.0, 1.4 Hz, 1H), 7.70 (d, J = 8.7 Hz, 1H), 7.82 (d, J = 8.7 Hz, 1H), 
8.53 (br s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 103.77, 114.16, 116.60, 120.70, 
127.42, 127.75, 127.92, 129.32, 130.92, 133.46, 135.13, 143.73. HRMS (ESI) m/z calcd. 




Yellow solid, mp 141-142 °C (ethanol). 1H NMR (CDCl3, 300 MHz): δ (ppm) 2.39 (s, 
3H), 6.82 (dd, J = 3.3, 2.0 Hz, 1H), 7.26 (AA’BB’, 4H), 7.42 (dd, J = 3.2, 2.5 Hz, 1H), 
7.47-7.62 (m, 3H), 7.96-8.02 (m, 2H), 8.54 (br s, 1H), 8.55 (s, 1H). 13C NMR (CDCl3, 
75 MHz): δ (ppm) 21.34, 105.28, 116.15, 120.21, 123.79, 124.96, 127.29, 127.93, 
128.68, 128.95, 129.29, 130.14, 133.17, 136.20, 139.75, 141.81, 149.47. HRMS (ESI) 









Yellow oil. 1H NMR (CDCl3, 300 MHz): δ (ppm) 2.35 (s, 3H), 6.65 (dd, J = 3.3, 2.1 Hz, 
1H), 7.15–7.30 (m, 4H), 7.35–7.49 (m, 4H), 7.65 (d, J = 1.7 Hz, 1H), 7.88-7.92 (m, 2H), 
8.22 (d, J = 1.6 Hz, 1H), 8.60 (br s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 21.25, 
104.66, 120.28, 120.81, 126.56, 126.66, 127.35, 127.95, 128.06, 129.08, 130.06, 132.54, 
133.16, 134.37, 136.02, 138.28, 142.92. HRMS (ESI) m/z calcd. for C21H18NO2S [M + 




Brown solid, mp 222-224 °C (taken-up with petroleum ether/DCM).1H NMR (acetone-
d6, 300 MHz): δ (ppm) 3.33 (s, 3H), 7.19 (dd, J = 3.3, 1.8 Hz, 1H), 7.97 (t, J = 3.0 Hz, 
1H), 8.25 (q, J = 0.8 Hz, 1H), 8.29 (br s 2H), 8.55 (s, 1H), 11.34 (br s, 1H).13C NMR 
(acetone-d6, 75 MHz): δ (ppm) 43.06, 102.68, 117.18, 122.52 (app. quint., J = 3.77 Hz), 
123.50 (q, J = 273.08 Hz), 124.38, 128.23, 129.66 (app. d, J = 3.64 Hz), 131.36, 131.74 
(q, J = 33.33 Hz), 134.69, 136.50, 136.89, 140.65. HRMS(ESI) m/z calcd. for 




Grey solid, mp 238-240 °C (taken-up with petroleum ether/DCM). 1H NMR (acetone-
d6, 300 MHz): δ (ppm) 2.51 (3H, s), 6.62 (dd, J = 3.1, 2.0 Hz, 1H), 7.05 (ddt, J = 8.0, 
1.4, 0.7 Hz, 1H), 7.23 -7.30 (m, 2H), 7.35 (dt, J = 1.5, 0.8 Hz, 1H), 7.58 (dd, J = 8.5, 0.8 
Hz, 1H), 8.30 (d, J = 8.0 Hz, 1H), 10.25 (br s, 1H), 10.68 (br s, 1H). 13C NMR (acetone-
d6, 75 MHz): δ (ppm) 22.12, 103.70, 105.52, 108.46, 111.65, 119.40, 120.60, 121.07, 
121.36, 122.29, 122.45, 130.85, 134.29, 138.06, 140.34. HRMS (ESI) m/z calcd. for 




Grey glassy solid. 1H NMR (acetone-d6, 300 MHz): δ (ppm) 6.63 (dd, J = 3.2, 2.0 Hz, 
1H), 7.21 (ddd, J 8.1, 7.2, 1.1 Hz, 1H), 7.28-7.32 (m, 2H), 7.35 (ddd, J = 8.2, 7.2, 1.2 Hz, 
1H), 7.56 (dt, J = 8.1, 1.0 Hz, 1H), 7.64 (dd, J = 8.5, 0.8 Hz, 1H), 8.43 (ddd, J = 7.8, 1.3, 
0.7 Hz, 1H), 10.38 (br s, 1H), 10.72 (br s, 1H). 13C NMR (acetone-d6, 75 MHz): δ (ppm) 
130.78, 105.51, 108.43, 111.54, 119.50, 120.03, 121.63, 122.47, 122.53, 122.75, 124.62, 





Whitish solid, mp 214-217 °C (taken-up with petroleum ether/DCM). 1H NMR (acetone-
d6, 300 MHz): δ (ppm) 3.88 (s, 3H), 6.61 (dd, J = 3.2, 1.9 Hz, 1H), 6.86 (dd, J = 8.6, 2.3 
Hz, 1H), 7.09 (d, J = 2.4 Hz, 1H), 7.25 (d, J = 8.7 Hz, 1H), 7.28 (dd, J = 3.0, 2.4 Hz, 1H), 
7.55 (dd, J = 8.5, 0.7 Hz, 1H), 8.30 (d, J = 8.6 Hz, 1H), 10.27 (br s, 1H), 10.68 (br s, 1H). 
13C NMR (acetone-d6, 75 MHz): δ (ppm) 55.78, 95.41, 103.63, 105.44, 107.52, 107.78, 
116.80, 118.52, 122.21, 122.50, 122.62, 130.58, 137.97, 141.13, 158.86. HRMS (ESI) 




Yellow solid, mp 177-180 °C (taken-up with petroleum ether/DCM). 1H NMR (CDCl3, 
300 MHz): δ (ppm) 6.66 (dt, J = 3.8, 2.0 Hz, 1H), 7.22 (dt, J = 8.4, 2.0 Hz, 1H), 7.28– 
7.37 (m, 2H), 7.59 (t, J = 1.7 Hz, 1H), 7.68 (dd, J = 8.5, 1.8 Hz, 1H), 8.43 (dd, J = 8.4, 
1.5 Hz, 1H), 10.55 (s, 1H), 10.81 (s, 1H). 13C NMR (CDCl3, 75 MHz): δ (ppm) 103.85, 
103.94, 105.56, 107.98, 111.37, 119.72, 120.64, 121.52, 122.64, 122.87, 129.82, 130.61, 







Grey solid, mp 227-230 °C (taken-up with petroleum ether/DCM). 1H NMR (acetone-
d6, 300 MHz): δ (ppm) 6.74 (dd, J = 3.2, 1.8 Hz, 1H), 7.37 (dd, J = 3.2, 2.6 Hz, 1H), 
7.43-7.50 (m, 2H), 7.65-7.72 (m, 2H), 7.84 (AB, J 17.6, 8.8 Hz, 2H), 8.05 (dm, J = 8.0 
Hz, 1H), 9.06 (ddt, J = 8.4, 1.3, 0.7 Hz, 1H), 10.60 (br s, 1H), 10.99 (br s, 1H),13C NMR 
(acetone-d6, 75 MHz): δ (ppm) 104.61, 106.37, 109.87, 114.24, 116.12, 119.57, 122.56, 
123.33, 123.67, 124.88, 126.52, 126.97, 130.11, 130.19, 130.30, 130.38, 137.09, 137.53. 




Whitish solid, mp 181-182 °C (taken-up with petroleum ether/DCM). 1H NMR (CDCl3, 
300 MHz): δ (ppm) 6.59 (dd, J = 3.1, 2.0 Hz, 1H), 7.21 (d, J = 5.2 Hz, 1H), 7.24-7.30 
(m, 2H), 7.42-7.48 (m, 2H), 10.51 (br s, 1H), 10.68 (br s, 1H). 13C NMR (CDCl3, 300 
MHz): δ (ppm) 103.77, 106.83, 108.46, 112.68, 115.34, 117.05, 122.00, 122.27, 126.26, 
128.71, 139.53, 142.98. HRMS (ESI) m/z calcd. for C12H9N2S [M + H]+: 213.0481, found 
213.0499. 
 
2'-Methyl-2-phenyl-3-(phenylthio)spiro[cyclopentane-1,3'-indolin]-2-en-4-one 76a  
 
 
yellow solid, mp 155–157 °C. 1H NMR (400 MHz, CDCl3) δ 7.36–7.21 (m, 11H), 6.92 
(t, J = 7.7 Hz, 1H), 6.62 (d, J = 7.8 Hz, 2H), 4.06 (q, J = 6.5 Hz, 1H), 3.78 (br s, 1H), 
3.24 (d, J = 19.0 Hz, 1H), 2.67 (d, J = 19.0 Hz, 1H), 1.23 (d, J = 6.5 Hz, 3H). 13C NMR 
(100 MHz, CDCl3) δ 202.6, 177.0, 151.6, 135.9, 135.3, 133.8, 131.2, 129.4, 129.2, 129.1, 
128.8, 127.9, 127.6, 126.4, 123.4, 120.1, 110.6, 66.0, 58.5, 48.6, 14.2. HRMS (ESI+) m/z 
calcd. for C25H22NOS [MH]+: 384.1417, found: 384.1411 (1.6 ppm). ῦmax (thin film)/cm-





yellow solid, mp 59–61 °C. 1H NMR (400 MHz, CDCl3) δ 7.23-7.12 (m, 7H), 6.91 (t, J 
= 7.7 Hz, 1H), 6.70–6.65 (m, 5H), 4.09 (q, J = 6.7 Hz, 1H), 3.74 (s, 3H), 3.25 (d, J = 
18.9 Hz, 1H), 2.67 (d, J = 19.0 Hz, 1H), 1.22 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ 202.7, 177.0, 160.3, 151.6, 134.6, 134.1, 131.5, 129.7, 129.3, 128.8, 127.5, 
126.3, 123.5, 120.1, 113.0, 110.5, 66.1, 58.4, 55.0, 49.4, 14.4. HRMS (ESI+) calcd. for 
C26H24NO2S [MH]+: 141.1522, found: 414.1526 (–1.0 ppm). ῦmax (thin film)/cm-1: 1707, 






yellow solid, mp: 57–59 °C. 1H NMR (400 MHz, CDCl3) δ 7.23–7.12 (m, 7H), 6.91 (td, 
J = 7.4, 0.9 Hz, 1H), 6.85–6.80 (m, 2H), 6.66-6.63 (m, 3H), 4.08 (q, J = 6.7 Hz, 1H), 
3.25 (d, J = 19.1 Hz, 1H), 2.68 (d, J = 19.1 Hz, 1H), 1.23 (d, J = 6.7 Hz, 3H). 13C NMR 
(100 MHz, CDCl3) δ 202.5, 175.6, 162.9 (d, J1 = 249.7 Hz), 151.5, 136.2, 133.5, 130.1 
(d, J4 = 3.2 Hz), 130.9, 130.0 (d, J3 = 8.5 Hz), 129.5, 129.3, 128.9, 126.6, 123.3, 120.1, 
114.8 (d, J2 = 21.9 Hz, 1H), 110.5, 65.9, 58.4, 48.7, 14.3. 19F NMR (376 MHz, CDCl3) 
δ –111.09 to –111.16 (m). HRMS (ESI+) calcd. for C25H20NNaOS [MNa]+: 424.1142, 






yellow solid, mp: 74–76 °C. 1H NMR (400 MHz, CDCl3) δ 7.26–7.12 (m, 5H), 7.13 (d, 
J = 7.9 Hz, 2H), 6.89 (t, J = 7.4 Hz, 1H), 6.74 (d, J = 9.0 Hz, 2H), 6.69 (d, J = 7.8 Hz, 
1H), 6.45 (d, J = 9.0 Hz, 2H), 4.11 (q, J = 6.6 Hz, 1H), 3.24 (d, J = 18.8 Hz, 1H), 2.92 
(s, 6H), 2.67 (d, J = 18.8 Hz, 1H), 1.20 (d, J = 6.6 Hz, 3H). 13C NMR (100 MHz, CDCl3) 
δ 202.8, 178.2, 151.6, 150.9, 135.0, 132.4, 131.9, 130.0, 129.1, 128.8, 128.3, 128.0, 
125.9, 123.7, 122.4, 120.1, 110.4, 66.3, 58.3, 50.5, 39.9, 14.6. HRMS (ESI+) calcd. for 
C27H27N2OS [MH]+: 427.1839, found: 427.1840 (-0.3 ppm). ῦmax (thin film)/cm-1: 1702, 







yellow solid, mp:138–140 °C. 1H NMR (400 MHz, CDCl3) δ 7.35–7.33 (m, 2H), 7.28–
7.23 (m, 6H), 6.88 (dd, J = 8.5, 2.4 Hz, 1H), 6.81 (d, J = 2.4 Hz, 1H), 6.74 (d, J = 8.2 
Hz, 2H) 6.70 (d, J = 8.2 Hz, 2H), 4.13 (q, J = 6.6 Hz, 1H), 3.89 (s, 3H), 3.30 (d, J = 19.1 
Hz, 1H), 2.76 (d, J = 19.1 Hz, 1H), 1.32 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3) 
δ 202.5, 177.1, 154.6, 145.4, 135.9, 135.2, 133.8, 133.0, 129.3, 129.2, 128.8, 128.0, 
127.6, 126.5, 115.0, 112.0, 109.2, 66.4, 59.1, 56.0, 48.3, 14.2. HRMS (ESI+) m/z calcd. 
for C26H23NNaO2S [MNa]+: 436.1342, found: 436.1342 (0.0 ppm error). ῦmax (thin 
film)/cm-1 1712, 1490, 1439, 1223, 738. 
 
 2-Cyclopropyl-2'-methyl-3-(phenylthio)spiro[cyclopentane-1,3'-indolin]-2-en-4-one 76f 
 
 
yellow solid, mp: 65–67 °C. 1H NMR (400 MHz, CDCl3) δ 7.36–7.32 (m, 2H), 7.26–
7.21 (m, 4H), 7.09 (d, J = 7.5 Hz, 1H), 6.93 (app t, J = 7.8 Hz, 1H), 6.81 (d, J = 7.8 Hz, 
1H), 4.19 (q, J = 6.6 Hz, 1H), 3.15 (d, J = 19.1 Hz, 1H), 2.58 (d, J = 19.1 Hz, 1H), 1.83-
1.67 (m, 3H), 1.49 (d, J = 6.5 Hz, 3H), 1.18-1.13 (m, 1H), 0.98-0.94 (m, 1H). 13C NMR 
(100 MHz, CDCl3) δ 203.0, 189.6, 150.9, 135.7, 132.1, 129.0, 128.9, 127.1, 125.8, 125.8, 
123.4, 120.0, 110.2, 65.9, 59.3, 48.7, 15.2, 14.4, 12.9, 12.3. HRMS (ESI+) m/z calcd. for 
C22H21NNaOS [MNa]+: 370.1236, found: 370.1235 (0.2 ppm). ῦmax (thin film)/cm-1 





yellow solid, mp: 59–61 °C. 1H NMR (400 MHz, CDCl3) δ 7.13–7.02 (m, 10H), 6.99 (d, 
J = 7.5 Hz, 1H), 6.87 (s, 1H), 6.85 (s, 1H), 6.76 (t, J = 7.5 Hz, 1H), 6.56 (d, J = 7.8 Hz, 
1H), 3.69 (d, J = 9.8 Hz, 1H), 3.61 (br, 1H), 3.51 (d, J = 9.8 Hz, 1H), 2.96 (d, J = 18.8 
Hz, 1H), 2.85 (d, J = 18.8 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 203.2, 176.8, 151.1, 
134.8, 134.0, 133.55, 131.8, 129.8, 129.5, 129.3, 129.0, 128.3, 128.1, 126.8, 122.8, 
119.9, 110.5, 57.6, 56.4, 52.4. HRMS (ESI+) m/z calcd. for C24H19NNaOS [MNa]+: 






yellow solid, mp: 58–60 °C. 1H NMR (400 MHz, CDCl3) δ 7.57–7.39 (m, 7H), 7.14 (t, 
J = 7.3 Hz, 1H), 6.97 (d, J = 7.8 Hz, 1H), 6.53 (s, 2H), 4.11 (d, J = 9.9 Hz, 1H), 4.10 (s, 
3H), 3.94 (d, J = 9.9 Hz, 1H), 3.82 (s, 6H), 3.39 (d, J = 18.8 Hz, 1H) 3.25 (d, J = 18.8 
Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 203.1, 175.7, 152.4, 151.2, 145.1, 138.7, 133.8, 
133.5, 132.1, 129.4, 129.2, 128.8, 126.6, 122.9, 119.6, 110.2, 105.8, 60.8, 57.8, 56.3, 
55.6, 52.6. HRMS (ESI+) m/z calcd. for C27H26NO4S [MH]+: 460.1577, found: 460.1578 





yellow solid, mp: 139–140 °C. 1H NMR (400 MHz, CDCl3) δ 7.32 (d, J = 8.4 Hz, 2H), 
7.21-7.13 (m, 6H), 7.04 (d, J = 7.5 Hz, 1H), 6.83 (t, J = 7.4 Hz, 1H), 6.78 (d, J = 8.4 Hz, 
2H), 6.64 (d, J = 7.8 Hz, 1H), 3.73 (d, J = 9.9 Hz, 1H), 3.62 (d, J = 9.9 Hz, 1H), 3.06 (d, 
J = 18.9 Hz, 1H), 2.91 (d, J = 18.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 202.8, 174.8, 
151.0, 135.2, 132.9, 132.7, 131.2, 131.1, 130.0, 129.7, 129.3, 128.9, 126.9, 123.8, 122.6, 
119.8, 110.4, 57.4, 56.1, 51.9; HRMS (ESI+) m/z calcd. for C24H19BrNOS [MH]+: 





yellow soli, mp: 62–63 °C. 1H NMR (400 MHz, CDCl3) δ 7.60–7.4 (m, 6H), 7.27 (d, J 
= 7.2 Hz, 1H), 7.11 (t, J = 7.3 Hz, 1H), 7.03 (d, J = 7.8 Hz, 1H), 4.39 (d, J = 9.9 Hz, 1H), 
4,26 (br s, 1H), 3.95 (d, J = 9.8 Hz, 1H), 3.15 (app s, 2H), 2.10–1.97 (m, 2H), 1.72–1.66 
(m, 1H), 1.41–1.34 (m, 1H), 1.28-1.18 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 203.1, 
188.3, 151.1, 135.3, 131.8, 129.0, 128.9, 127.4, 127.2, 125.9, 123.0, 119.6, 110.2, 58.6, 
56.9, 51.4, 13.8, 12.2, 10.7. HRMS (ESI+) m/z calcd. for C21H20NOS [MH]+: 334.1260, 








1'-Methyl-2-phenyl-3-(phenylthio)spiro[cyclopentane-1,3'-indolin]-2-en-4-one 76k  
 
 
yellow solid, mp 140–142 °C. 1H NMR (400 MHz, CDCl3) δ 7.35-7.18 (m, 8H), 7.08 (d, 
J = 7.5 Hz, 1H), 7.04-7.02 (m, 2H), 6.84 (t, J = 7.5 Hz, 1H), 6.55 (d, J = 7.9 Hz, 1H), 
3.56 (d, J = 9.3 Hz, 1H), 3.45 (d, J = 9.3 Hz, 1H), 3.05 (d, J = 18.2 Hz, 1H), 2.99 (d, J = 
18.2 Hz, 1H), 2.71 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 203.0, 176.2, 152.5, 135.0, 
133.9, 133.5, 132.4, 129.6, 129.3, 129.2, 128.8, 128.4, 127.9, 126.6, 122.3, 118.6, 107.7, 
65.6, 55.1, 52.1, 35.4. HRMS (ESI+) m/z calcd. for C25H21NNaOS [MNa]+: 406.1236, 
found: 406.1231 (1.2 ppm error). ῦmax (thin film)/cm-1: 1713, 1604, 1490, 740, 697. 
 
1',5,5-Trimethyl-2-phenyl-3-(phenylthio)spiro[cyclopentane-1,3'-indolin]-2-en-4-one 76l  
 
 
yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.29–7.15 (m, 9H), 7.03 (s, 1H),6.99 (s, 1H), 
6.73–6.68 (m, 2H), 6.51 (d, J = 8.0 Hz, 1H), 3.52 (d, J = 11.1 Hz, 1H), 3.35 (d, J = 11.1 
Hz, 1H), 2.07 (s, 3H), 1.33 (s, 3H), 0.91 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 208.6, 
174.1, 152.7, 134.2, 133.8, 131.8, 131.0, 129.8, 129.2, 129.1, 128.8, 128.1, 128.0, 126.7, 
124.1, 118.1, 107.8, 63.8, 58.6, 53.2, 35.7, 26.9, 19.2. HRMS (ESI+) m/z calcd. for 
C27H26NNaOS [MNa]+: 434.1544, found: 434.1549 (1.1 ppm). ῦmax (thin film)/cm-1: 
2970, 1713, 1491, 739, 697. 
 
2-Phenyl-3-(phenylthio)spiro[cyclohesane-1,3'-indolin]-2-en-4-one 76m  
 
 
yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.24–7.10 (m, 11H), 6.82 (t, J = 7.1 Hz, 2H), 
6.63 (d, J = 7.8 Hz, 2H), 3.61 (d, J = 9.3 Hz, 1H), 3.35 (d, J = 9.3 Hz, 1H), 2.88 (ddd, J 
= 17.5, 12.5, 4.8 Hz, 1H), 2.65 (dt, J = 17.5, 4.8 Hz, 1H), 2.50 (dt, J = 12.5, 4.8 Hz, 1H), 
2.39 (td, J = 12.5, 4.8 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 194.3, 168.1, 150.9, 
138.7, 136.5, 134.1, 129.8, 129.1, 128.7, 128.7, 127.9, 127.8, 127.0, 125.9, 124.4, 118.8, 
110.7, 58.9, 53.4, 34.84, 34.80. HRMS (ESI+) m/z calcd. for C25H21NNaOS [MNa]+: 





yellow oil. Diastereoisomer I: 1H NMR (400 MHz, CDCl3) δ 7.40–7.11 (m, 10H), 6.97 
(d, J = 7.5Hz, 2H), 6.76 (td, J = 7.5, 2.0 Hz, 1H), 6.42 (d, J = 7.8 Hz, 1H), 4.80 (d, J = 
7.0 Hz, 1H), 3.40 (d, J = 9.0 Hz, 1H), 3.25 (d, J = 9.0 Hz, 1H), 2.62 (s, 3H), 2.52 (dd, J 
= 14.2, 7.0 Hz, 1H), 2.38 (dd, J = 14.2, 2.8 Hz, 1H), 2.17 (d, J = 2.8 Hz, 1H). 13C NMR 
(100 MHz, CDCl3) 152.3, 152.0, 135.0, 134.6, 133.6, 130.4, 129.1, 128.6, 128.3, 127.8, 
127.7, 127.0, 124.3, 118.3, 107.3, 99.9, 74.8, 66.3, 59.9, 48.1, 35.7. HRMS (ESI) m/z 
calcd. for C25H24NOS [MH]+:  386.1574, found: 386.1573 (0.2 ppm). ῦmax (thin film)/cm-
1: 2925, 1603, 1490, 741, 697. 
 
Distereoisomer II: 1H NMR (400 MHz, CDCl3) δ 7.43-7.40 (m, 2H), 7.33–7.13 (m, 7H), 7.08 (dd, J = 7.3, 1.1 
Hz, 1H), 7.01-6.97 (m, 2H), 6.74 (td, J = 7.3, 1.1 Hz, 1H), 6.46 (d, J = 8.0 Hz, 1H), 4.93 (app t, J = 5.6 Hz, 1H), 
3.43 (d, J = 9.4 Hz, 1H), 3.31 (d, J = 9.4 Hz, 1H), 2.80 (dd, J = 13.5, 7.0 Hz, 1H), 2.64 (s, 3H), 2.22 (dd, J = 13.5, 
5.8 Hz, 1H), 2.14 (s broad, 1H). 13C NMR (100 MHz, CDCl3) δ 152.5, 150.6, 135.9, 134.84, 134.79, 133.0, 131.1, 
129.2, 129.0, 128.5, 127.8, 127.7, 127.3, 122.5, 117.9, 107.5, 74.6, 66.8, 59.2, 49.3, 35.5. HRMS (APCI) m/z 






yellow solid, mp: 59–60 °C. 1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 7.7 Hz, 1H), 
7.33–7.27 (m, 1H), 7.21–7.07 (m, 7H), 7.01 (app t, J = 7.7 Hz, 2H), 6.74 (d, J = 7.8 Hz, 
2H), 2.85 (d, J = 19.2 Hz, 1H), 2.77 (d, J = 19.2 Hz, 1H), 2.13 (s, 3H). 13C NMR (100 
MHz, CDCl3 ) 201.2, 181.4, 171.5, 155.1, 140.7, 137.2, 132.6, 132.4, 130.3, 130.1 129.2, 
129.0, 128.3, 127.1, 127.0, 126.5, 121.7, 120.7, 67.1, 43.3, 16.0. HRMS (ESI+) m/z calcd. 
for C25H19NNaOS [MNa]+: 404.1080, found: 404.1079 (0.1 ppm error). ῦmax (thin 








yellow solid, mp 64–65 °C. 1H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 7.7 Hz, 1H), 7.31 
(td, J = 6.8, 2.2 Hz, 1H), 7.22–7.07(m, 7H), 6.80 (app d, J = 8.9 Hz, 2H), 6.54 (app d, J 
= 8.9 Hz, 2H), 3.61 (s, 3H), 2.81 (d, J = 18.5 Hz, 1H), 2.72 (d, J = 18.5 Hz, 1H), 2.10 (s, 
3H). 13C NMR (100 MHz, CDCl3) δ 201.1, 182.2, 171.3, 161.3, 155.0, 141.4, 134.9, 
133.1, 129.5, 129.2, 129.1, 129.0, 126.9, 126.6, 124.8, 121.7, 120.8, 113.8, 67.0, 55.2, 
43.6, 15.9. HRMS (ESI+) m/z calcd. for C26H21NNaO2S [MNa]+: 434.1185, found: 
434.1180 (1.2 ppm error). ῦmax (thin film)/cm-1: 1711, 1603, 1578, 1505, 1253, 1178, 





yellow solid, mp: 54–56 °C. 1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 7.6 Hz, 1H), 7.26 
(dt, J = 6.6, 2.2 Hz, 1H), 7.15–7.03 (m, 7H), 6.71–6.63 (m, 4H), 2.80 (d, J = 18.5 Hz, 
1H), 2.72 (d, J = 18.5 Hz, 1H), 2.08 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 201.0, 181.3, 
169.7, 163.5 (d, J1 = 252.4 Hz), 155.0, 140.6, 137.3, 132.2, 130.2, 129.3, 129.3, 129.2 
(d, J3= 9.0 Hz), 128.4 (d, J4 = 3.5 Hz), 127.3, 126.6, 121.7, 120.8, 115.5 (d, J2 = 22.0 Hz, 
1H), 67.1, 43.2, 15.9. 19F NMR (376 MHz, CDCl3) δ (-108.63)–(-108.70) (m, 1F). 
HRMS (ESI+) m/z calcd. for C25H19FNOS [MH]+: 400.1166, found: 400.1168 (-0.5 ppm 





yellow solid, mp: 60–62°C. 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 7.9 Hz, 1H), 7.38 
(dt, J = 7.4, 1.5, 1H), 7.27–7.16 (m, 7H), 2.74 (d, J = 19.0 Hz, 1H), 2.69 (d, J = 19.0 Hz, 
1H), 2.25 (s, 3H), 1.26–1.16 (m, 2H), 0.93–0.73 (m, 3H). 13C NMR (100 MHz, CDCl3) 
δ 201.1, 182.9, 182.0, 155.2, 140.6, 134.3, 132.2, 129.2, 129.2, 128.3, 126.6, 126.5, 
121.9, 120.7, 67.3, 42.4, 15.9, 14.0, 11.5, 10.0. HRMS (ESI+) m/z calcd. for C22H20NOS 







a yellow solid, mp: 59–61 °C.1H NMR (400 MHz, CDCl3) δ 7.33 (d, J = 8.5 Hz, 1H), 
7.18–7.01 (m, 7H), 6.78–6.74 (m, 3H), 6.66 (d, J = 2.4 Hz, 1H), 3.67 (s, 3H), 2.81 (d, J 
= 19.1 Hz, 1H), 2.70 (d, J = 19.1 Hz, 1H), 2.06 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 
201.2, 179.0, 171.6, 158.8, 148.7, 142.4, 137.0, 132.6, 132.4, 130.4, 130.1, 129.0, 128.3, 
127.1, 127.1, 121.1, 113.8, 108.1, 67.2, 55.7, 43.6, 15.8. HRMS (ESI+) m/z calcd. for 
C26H21NO2S [MH]+: 412.1366, found: 412.1368 (-0.6 ppm error). vmax (thin film)/cm-1 





yellow solid, mp: 168–170 °C. 1H NMR (400 MHz, CDCl3) δ 7.30–7.16 (m, 7H), 6.96-
6.93 (m, 3H), 6.75 (t, J = 7.1 Hz, 1H), 6.63 (d, J = 8.7 Hz, 2H), 6.47 (d, J = 7.1 Hz, 1H), 
5.16 (s, 1H), 3.46 (d, J = 9.6 Hz, 1H), 3.36 (d, J = 9.6 Hz, 1H), 2.94 (d, J = 18.8 Hz, 1H), 
2.89 (d, J = 18.8 Hz, 1H), 2.64 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 203.7, 174.6, 
173.3, 155.3, 152.4, 136.4, 134.0, 133.4, 132.5, 129.2, 128.4, 127.9, 123.3, 122.2, 118.5, 
116.0, 107.7, 65.5, 54.9, 52.2, 35.4. HRMS (ESI+) m/z calcd. for C25H22NO2S [MH]+: 
400.1366, found: 400.1365 (0.3 ppm error). ῦmax (thin film)/cm-1 3372, 1697, 1602, 1582, 





yellow solid, mp: 125–127 °C. 1H NMR (400 MHz, CDCl3) 7.24-7.10 (m, 6H), 6.97-
6.91 (m, 5H), 6.72 (td, J = 7.6, 2.4 Hz, 1H), 6.57 (d, J = 7.9 Hz, 1H), 3.43 (d, J = 9.4 Hz, 
1H), 3.33 (d, J = 9.4 Hz, 1H), 2.91 (d, J = 18.9 Hz, 1H), 2.84 (d, J = 18.9 Hz, 1H), 2.59 
(s, 3H), 2.22 (s, 3H). 13C NMR (100 MHz, CDCl3) 203.1, 175.3, 152.4, 136.8, 135.5, 
133.9, 132.5, 130.2, 129.8, 129.6, 129.2, 129.1, 128.4, 127.9, 122.2, 118.5, 107.6, 65.6, 
54.9, 52.2, 35.4, 21.0. HRMS (ESI+) m/z calcd. for C26H23NNaOS [MNa]+: 420.1393, 










yellow solid, mp: 125–127 oC. 1H NMR (400 MHz, CDCl3) δ 7.18–7.15 (m ,2H), 7.12–
7.08 (m, 2H), 7.05 (d, J = 7.7 Hz, 1H), 6.81 (d, J = 7.3 Hz, 2H), 6.77 (t, J = 7.2 Hz, 1H), 
6.90 (d, J = 7.5 Hz, 2H), 6.83–6.75 (m, 3H), 6.43 (d, J = 8.0 Hz, 1H), 3.42 (d, J = 8.9 
Hz, 1H), 3.31 (d, J = 8.9 Hz, 1H), 2.92 (d, J = 19.1 Hz, 1H), 2.86 (d, J = 19.1 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ 202.9, 169.7, 152.6, 142.3, 135.8, 133.7, 132.4, 129.0, 
128.9, 128.5, 128.4, 127.8, 127.6, 127.5, 122.4, 118.3, 107.6, 65.7, 54.8, 51.4, 35.3, 22.1. 
HRMS (ESI+) m/z calcd. for C27H26NOS [MH]+: 412.1729, found: 412.1729 (0.2 ppm). 





yellow solid, mp: 141–143 °C. 1H NMR (400 MHz, CDCl3) δ 7.55–7.50 (m, 2H), 7.46–
7.39 (m, 4H), 7.37–7.24 (m, 4H), 7.24–7.16 (m, 3H), 7.04 (dd, J = 7.4, 1.0 Hz, 1H), 
7.01–6.96 (m, 2H), 6.78 (td, J = 7.4, 0.8 Hz, 1H), 6.49 (d, J = 7.9 Hz, 1H), 3.51 (d, J = 
9.5 Hz, 1H), 3.40 (d, J = 9.5 Hz, 1H), 3.03(d, J = 18.7 Hz, 1H), 2.97 (d, J = 18.7 Hz, 
1H), 2.65 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 203.2, 176.2, 152.6, 140.4, 139.7, 
135.0, 133.9, 132.5, 132.4, 130.1, 129.4, 129.3, 128.8, 128.5, 128.0, 127.6, 127.4, 127.0, 
122.3, 118.6, 107.8, 65.7, 55.2, 52.2, 35.4. HRMS (ESI+) calcd. for C31H25NNaOS 
[MNa]+: 482.1549, found: 482.1556 (-0.3 ppm error). ῦmax (thin film)/cm-1: 1714, 1603, 
1490, 1479, 760, 743, 697. 
 
Methyl 2-((1'-methyl-4-oxo-2-phenylspiro[cyclopentane-1,3'-indolin]-2-en-3-yl)thio)benzoate 79e 
 
 
yellow solid, mp: 149–151 oC. 1H NMR (400 MHz, CDCl3) δ 7.97 (dd, J  =  7.7, 1.6 Hz, 
1H), 7.37 (td, J = 7.6, 1.6 Hz, 1H), 7.30–7.26 (m, 1H), 7.23–7.18 (m, 4H), 7.13 (d, J = 
7.6 Hz, 1H), 7.08 (d, J = 7.7 Hz, 1H), 7.04–7.02 (m, 2H), 6.79 (app t, J = 7.4 Hz, 1H), 
6.51 (t, J = 7.7 Hz, 1H), 3.89 (s, 3H), 3.55 (d, J = 9.1 Hz, 1H), 3.44 (d, J = 9.1 Hz, 1H), 
3.05 (d, J = 18.7 Hz, 1H), 2.98 (d, J = 18.7 Hz, 1H), 2.67 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ 202.9, 179.2, 166.6, 152.5, 138.6, 134.3, 133.7, 132.3, 132.2, 131.5, 129.6, 
129.3, 128.3, 128.0, 127.8, 127.4, 125.0, 122.3, 118.6, 107.8, 65.7, 55.4, 52.2, 52.2, 35.4. 
HRMS (ESI+) m/z calcd. for C27H24NO3S [MH]+: 442.1472, found: 442.1471 (0.2 ppm). 





yellow solid. mp: 149–151 oC. 1H NMR (400 MHz, CDCl3) δ 7.29–7.22 (m, 2H), 7.21–
7.15 (m, 4H), 7.11–7.05 (m, 3H), 6.98–6.93 (m, 2H), 6.77 (td, J = 7.4, 1.0 Hz, 1H), 6.47 
(d, J = 7.9 Hz, 1H), 3.49 (d, J = 9.4 Hz, 1H), 3.38 (d, J = 9.4 Hz, 1H), 3.00 (d, J = 18.7 
Hz, 1H), 2.94 (d, J = 18.7 Hz, 1H), 2.63 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 202.6, 
175.9, 152.6, 134.5, 134.0, 133.8, 132.3, 132.1, 131.3, 129.9, 129.4, 129.3, 128.2, 128.0, 
128.0, 126.9, 122.6, 118.7, 107.9, 65.8, 55.3, 52.1, 35.5. HRMS (ESI+) m/z calcd. for 
C25H20ClNNaOS [MNa]+: 440.0846, found: 440.0833 (2.8 ppm error). ῦmax (thin 





yellow solid. mp: 120–122 °C. 1H NMR (400 MHz, CDCl3) δ 7.32–7.25 (m, 3H), 7.23–
7.16 (m, 3H), 7.12–7.07 (m, 2H), 6.98 (dd, J = 7.4, 1.0 Hz, 1H), 6.95–6.91 (m, 2H), 6.77 
(td, J = 7.4, 0.9 Hz, 1H), 6.48 (d, J = 7.9 Hz, 1H), 3.49 (d, J = 9.5 Hz, 1H), 3.38 (d, J = 
9.5 Hz, 1H), 2.98 (d, J = 18.7 Hz, 1H), 2.91 (d, J = 18.7 Hz, 1H), 2.64 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ 202.9, 176.6, 152.6, 134.6, 133.8, 132.7, 132.2, 132.0, 131.5, 129.6, 
129.4, 128.4, 128.1, 122.3, 120.8, 118.7, 107.8, 65.6, 55.2, 52.1, 35.4. HRMS (ESI+) m/z 
calcd. for C25H20BrNNaOS [MNa]+: 484.0341, found: 484.0343 (-0.7 ppm error). ῦmax 









yellow oil. 1H NMR (400 MHz, CDCl3) δ 8.05–8.02 (m, 2H), 7.30–7.17 (m, 6H), 7.00 
(app t, J = 7.5 Hz, 1H), 6.94–6.91 (m, 2H), 6.78 (dt, J = 7.4, 1.0 Hz, 1H), 3.51 (d, J = 
9.6 Hz, 1H), 3.41 (d, J = 9.6 Hz, 1H), 3.04 (d, J = 18.6 Hz, 1H), 2.95 (d, J = 18.6 Hz, 
1H), 2.63 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 202.2, 179.5, 152.5, 145.8, 143.7, 
133.3, 132.1, 131.6, 130.0, 129.6, 128.2, 128.1, 127.8, 124.0, 122.1, 118.7, 107.9, 65.5, 
55.5, 51.9, 35.3. HRMS (ESI+) m/z calcd. for C25H21N2O3S [MH]+:  429.1267, found: 





yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.51–7.47 (m, 3H), 7.4 (app t, J = 7.8 Hz, 1H), 
7.32 (d, J = 7.8 Hz, 1H), 7.32 (app d, J = 7.8 Hz, 1H), 7.12-7.04 (m, 3H), 6.97 (dd, J = 
8.4. 2.0 Hz, 1H), 6.78 (d, J = 8.4 Hz, 1H), 4.02 (s, 3H), 3.80 (d, J = 9.3 Hz, 1H), 3.69 (d, 
J = 9.3 Hz, 1H), 3.29 (d, J = 18.9 Hz, 1H), 3.23 (d, J = 18.9 Hz, 1H), 2.94 (s, 3H). 13C 
NMR (100 MHz, CDCl3) δ 203.0, 176.5, 159.6, 152.4, 134.7, 133.8, 132.3, 129.6, 129.3, 
129.2, 128.3, 127.9, 122.2, 121.7, 118.5, 114.8, 112.5, 107.7, 35.3. HRMS (ESI+) m/z 
calcd. for C26H23NNaO2S [MNa]+: 436.1341, found: 436.1342 (0.3 ppm). ῦmax (thin 
film)/cm-1: 1712, 1589, 1477, 1245, 1229, 728, 696. 
 
1'-Methyl-3-(naphthalen-2-ylthio)-2-phenylspiro[cyclopentane-1,3'-indolin]-2-en-4-one 79j  
 
 
yellow solid, mp: 129–133 °C. 1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 7.5 Hz, 1H), 
7.71–7.64 (m, 3H), 7.49–7.37 (m, 3H), 7.31 (dd, J = 8.7, 1.2 Hz, 1H), 7.26–7.12 (m, 
4H), 7.07 (d, J = 7.3 Hz, 1H), 7.03– 6.94 (m, 2H), 6.79 (t, J = 7.4 Hz, 1H), 6.49 (d, J = 
7.9 Hz, 1H), 3.52 (d, J = 9.3 Hz, 1H), 3.41 (d, J = 9.3 Hz, 1H), 3.02 (d, J = 18.7 Hz, 1H), 
2.95 (d, J = 18.7 Hz, 1H), 2.65 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 203.2, 176.6, 
152.6, 135.0, 133.9, 133.6, 132.5, 132.1, 130.8, 129.4, 129.3, 128.6, 128.6, 128.4, 128.0, 
127.7, 127.5, 127.3, 126.5, 126.0, 122.4, 118.6, 107.8, 65.6, 55.2, 52.2, 35.4. HRMS 
(ESI+) m/z calcd. for C29H23NNaOS+ [MNa]+: 456.1393, found: 456.1395 (–1.0 ppm 






yellow solid, mp: 85–86 °C. 1H NMR (400 MHz, CDCl3) δ 7.29–7.21 (m, 3H), 7.14 (t, 
J = 7.6 Hz, 1H), 6.97 (d, J = 7.5 Hz, 2H), 6.94 (d, J = 7.5 Hz, 1H), 6.71(t, J = 7.3 Hz, 
1H), 6.43 (d, J = 7.9 Hz, 1H), 3.39 (d, J = 9.6 Hz, 1H), 3.30 (d, J = 9.6 Hz, 1H), 2.89-
2.82 (m, 3H), 2.75-2.70 (m, 1H), 2.60 (s, 3H), 1.53-1.42 (m, 2H), 0.84 (t, J = 7.3 Hz, 
3H). 13C NMR (100 MHz, CDCl3) 204.4, 172.2, 152.4, 135.8, 134.4, 132.8, 129.1, 129.0, 
128.4, 127.9, 122.2, 118.5, 107.6, 65.6, 54.7, 52.3, 35.4, 33.0, 23.3, 13.1. HRMS (ESI+) 
m/z calcd. for C22H24NOS [MH]+: 350.1573, found: 350.1577 (-1.1 ppm error). ῦmax (thin 





yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.32-7.24 (m, 3H), 7.18 (t, J = 7.6 Hz, 1H), 
7.00–6.97 (m, 3H), 6.75 (t, J = 7.4 Hz, 1H), 6.47 (d, J = 7.9 Hz, 1H), 3.57–3.50 (m, 1H), 
3.43 (d, J = 9.4 Hz, 1H), 3.34 (d, J = 9.4 Hz, 1H), 2.92 (app s, 2H), 2.64 (s, 3H), 1.89–
1.81 (m, 2H), 1.69-1.55 (m, 3H), 1.26–1.13 (m, 5H). 13C NMR (100 MHz, CDCl3) 204.6, 
173.1, 152.4, 135.4, 134.5, 132.8, 129.0, 128.4, 127.9, 122.2, 118.5, 107.6, 65.6, 54.8, 
52.2, 42.4, 35.4, 33.5, 33.3, 25.8, 25.6. HRMS (ESI+) m/z calcd. for C25H27NNaOS 
[MNa]+: 412.1706, found: 412.1703 (0.6 ppm error). ῦmax (thin film)/cm-1: 1704, 1603, 





orange oil. 1H NMR (400 MHz, CDCl3) δ 7.34–7.20 (m, 4H), 7.05–6.99 (m, 3H), 6.80 
(t, J = 7.8 Hz, 1H), 6.50 (d, J = 7.9 Hz, 1H), 3.47 (d, J = 9.2 Hz, 1H), 3.38 (d, J = 9.2 
Hz, 1H), 3.03 (d, J = 19.0 Hz, 1H), 2.93 (d, J = 19.0 Hz, 1H), 2.65 (s, 3H), 1.22 (s, 9H). 
13C NMR (100 MHz, CDCl3) δ 205.8, 182.5, 152.6, 134.8, 134.6, 132.5, 129.2, 129.1, 
129.0, 127.6, 122.2, 118.4, 107.7, 65.6, 55.2, 51.6, 48.8, 35.3, 31.5. HRMS (ESI+) m/z 
calcd. for C23H26NOS [MH]+: 364.1730, found: 364.1730 (-0.2 ppm error). ῦmax (thin 







yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.28–7.22 (m, 5H), 7.17 (td, J = 7.4, 1.1 Hz, 
1H), 7.10–7.08 (m, 2H), 6.98 (dd, J = 7.4, 1.0 Hz, 1H), 6.73 (app t, J = 7.4 Hz, 1H), 6.45 
(d, J = 7.8 Hz, 1H), 3.41 (d, J = 7.8 Hz, 1H), 3.30 (d, J = 9.4 Hz, 1H), 2.93 (d, J = 18.3 
Hz, 1H), 2.88 (d, J = 18.3 Hz, 1H), 2.61 (s, 3H), 1.29-1.20 (m, 3H), 1.06 (d, J = 7.4 Hz, 
9H), 1.01 (d, J = 7.4 Hz, 9H). 13C NMR (100 MHz, CDCl3) δ 204.5, 174.9, 152.6, 135.1, 
134.9, 132.7, 128.9, 128.7, 128.7, 127.8, 122.5, 118.3, 107.6, 66.0, 55.1, 51.4, 35.4, 18.6, 
18.5, 14.2. HRMS (APCI) m/z calcd. for C28H38NOSSi [MH]+: 464.2452, found: 





yellow solid, mp:159–160 °C. 1H NMR (400 MHz, CDCl3) δ 7.25–7.01 (m, 9H), 6.66–
6.61 (m, 3H), 6.54 (d, J = 7.4 Hz, 1H), 6.40 (d, J = 7.8 Hz, 1H), 4.18 (d, J = 12.9 Hz, 
1H), 4.13 (d, J = 12.9 Hz, 1H), 3.30 (d, J = 9.6 Hz, 1H), 3.24 (d, J = 9.6 Hz, 1H), 2.85 
(s, 2H), 2.58 (s, 3H), 2.19 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 204.5, 175.7, 152.3, 
137.3, 135.4, 135.0, 134.1, 132.3, 130.6, 129.9, 128.9, 128.3, 127.7, 127.4, 125.7, 122.5, 
118.3, 107.5, 65.5, 54.8, 52.0, 35.4, 33.9, 19.0. HRMS (ESI+) m/z calcd. for 
C27H25NNaOS [MNa]+: 434.1549, found: 434.1549 (0.1 ppm error). ῦmax (thin film)/cm-






orange oil. 1H NMR (400 MHz, CDCl3) δ 7.28–7.18 (m, 3H), 7.13 (td, J = 7.9, 1.3 Hz, 
1H), 6.97 (d, J = 7.6 Hz, 1H), 6.94-6.91 (m, 2H), 6.42 (d, J = 8.1 Hz, 1H), 3.56 (s, 3H), 
3.38 (d, J = 9.5 Hz, 1H), 3.28 (d, J = 9.5 Hz, 1H), 3.19 (dt, J = 13.6, 7.2 Hz, 1H), 3.05 
(dt, J = 13.6, 7.2Hz, 1H), 2.90 (d, J = 19.0 Hz, 1H), 2.85 (d, J = 19.0 Hz, 1H), 2.59 (s, 
3H), 2.56-2.50 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 204.1, 173.1, 172.0, 152.4, 
134.8, 134.1, 132.5, 129.2, 129.1, 128.4, 128.0, 122.3, 118.5, 107.7, 65.6, 54.8, 52.3, 
51.7, 35.4, 35.1, 26.1. HRMS (ESI+) m/z calcd. for C23H24NO3S [MH]+: 394.1471, found: 




yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.45–7.22 (m, 10H), 7.14–7.10 (m, 
4H), 6.90 (td, J = 7.7, 1.2 Hz, 1H), 6.87 (td, J = 7.7, 1.2 Hz, 1H),  6.62 (s, 
1H), 6.61 (s, 1H), 4.56–4.48 (m, 2H), 3.85 (s, 3H), 3.82 (s, 3H), 3.71–3.63 
(m, 4H), 3.56 (d, J = 9.5 Hz, 1H), 3.54 (d, J = 9.5 Hz, 1H), 3.47 (d, J = 9.5 
Hz, 1H), 3.44 (d, J = 9.5 Hz, 1H), 3.26–3.17 (m, 2H), 3.05-2.86 (m, 8H), 2.78 
(s, 3H), 2.77 (s, 3H), 2.26–1.89 (m, 8H), 1.29 (d, J = 6.8 Hz, 3H), 1.23 (d, J 
= 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 204.30, 204.26, 173.54, 
173.50, 172.79, 172.74, 172.65, 172.31, 152.44, 152.39, 135.95, 135.60, 
134.20, 134.10, 132.70, 132.68, 129.22, 129.16, 129.12, 129.06, 128.62, 128.57, 127.9 (2xC), 122.51,  122.14, 
118.55, 118.38, 107.65, 107.62, 65.82, 65.62, 58.54, 58.46, 54.64, 54.59, 52.50, 52.34, 52.11 (2xC), 46.84, 46.75, 
39.66, 39.47, 35.40, 35.34, 34.69, 34.56, 29.03, 28.94, 24.70, 24.63, 16.97, 16.74. HRMS (APCI+) m/z calcd. for 
C29H33N2O4S [MH]+: 505.2162, found: 505.2156 (1.7 ppm). ῦmax (thin film)/cm-1: 2926, 1742, 1707, 1641, 1434, 
1198, 1174, 731, 699. 
3,3''-(Propane-1,3-diylbis(sulfanediyl))bis(1'-methyl-2-phenylspiro[cyclopentane-1,3'-indolin]-2-
en-4-one) 79r 
yellow solid, mp: 69–71 °C. 1H NMR (400 MHz, CDCl3) δ 7.29–7.20 (m, 6H), 
7.14 (app t, J = 7.6 Hz, 2H), 6.93 (app t, J = 7.0 Hz, 6H), 6.69 (app t, J = 7.4 
Hz, 2H), 6.44 (d, J = 7.9 Hz, 2H), 3.39 (d, J = 9.5 Hz, 2H), 3.29 (d, J = 9.5 
Hz, 2H), 2.90–2.82 (m, 6H), 2.78–2.72 (m, 2H), 2.61 (s, 6H), 1.71–1.60 (m, 
2H). 13C NMR (100 MHz, CDCl3) δ 204.2 (2xC), 173.0, 172.9, 152.4 (2xC), 
135.0 (2xC), 134.2 (2xC), 132.5 (2xC), 129.1 (2xC), 129.0 (2xC), 128.3 (2xC), 128.0 (2xC), 122.3 (2xC), 118.6 
(2xC), 107.6 (2xC), 65.6 (2xC), 54.8 (2xC), 52.2 (2xC), 35.4 (2xC), 30.0, 29.9, 29.3 (2xC). HRMS (ESI+) m/z 
calcd. for C41H39N2O2S2 [MH]+: 655.2447, found: 655.2443 (0.7 ppm error). ῦmax (thin film)/cm-1:1706, 1603, 





yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.15-7.05 (m, 3H), 6.97 (app t, J = 7.8 
Hz, 1H), 6.86 (dd, J = 7.4, 1.1 Hz, 0.5H), 6.81 (dd, J = 7.4, 1.1 Hz, 0.5H), 6.79–
6.76 (m, 2H), 6.66 (d, J = 7.8 Hz, 1H), 6.56 (td, J = 7.8, 2.3 Hz, 1H) 6.26 (d, J = 
7.8 Hz, 1H), 4.52–4.44 (m, 2H), 3.51 (s, 1.5 H), 3.47 (s, 1.5 H), 3.27–3.12 (m, 
3H), 3.05 (dd, J = 14.2, 5.1 Hz, 0.5H), 2.99 (dd, J = 14.2, 5.1 Hz, 1H), 2.77 (dd, 
J = 18.7, 2.5 Hz, 1H), 2.70 (dd, J = 18.7, 2.5 Hz, 1H), 2.43 (s, 3H), 1.83 (s, 1.5 
H), 1.79 (s, 1.5H). 13C NMR (100 MHz, CDCl3) δ 204.58, 204.51, 175.69, 
175.60, 170.99, 170.05, 152.44, 152.39, 134.19, 134.12, 133.85 (2xC), 131.90, 131.84, 129.39, 129.35, 129.20, 
129.18, 128.27 (2xC), 128.01 (2xC), 122.43, 122.36, 118.59 (2xC), 107.69 (2xC), 65.54, 65.46, 54.85, 54.78, 
52.56, 52.51, 52.00, 51.95, 51.82 (2xC), 35.34 (2xC), 33.45, 33.32, 22.95, 22.92. HRMS (ESI+) m/z calcd. for 




a yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.15 (td, J = 7.6, 1.7 
Hz, 1H), 7.04 (d, J = 7.0 Hz, 1H), 7.01–6.98 (m, 1H), 6.93–6.88 
(m, 2H), 6.75 (t, J = 7.6 Hz, 1H), 6.59–6.55 (m, 2H), 6.31 (d, J = 
7.6 Hz, 1H), 3.33 (d, J = 9.0 Hz, 1H), 3.28 (d, J = 9.0 Hz, 1H), 
2.92 (app d, J = 19.0 Hz, 1H), 2.86 (d, 19,0 Hz, 1H), 2.54 (s, 3H), 
2.45–2.34 (m ,2H), 2.29 (d, J = 3.3 Hz, 3H), 1.93 (d, J = 4.6 Hz, 3H), 1.67–1.06 (m, 26H), 0.89–0.84 (m, 12H). 
13C NMR (100 MHz, CDCl3) δ 204.09, 204.05, 167.13, 167.06, 152.56 (2xC), 152.13 (2xC), 139.03, 139.00, 
138.22, 138.18, 137.20, 137.17, 133.48, 133.46, 132.75(2xC), 128.82 (2XC), 127.68, 127.64, 127.19, 127.15, 
126.61, 126.59, 122.80 (2xC), 122.35 (2xC), 118.28, 118.23, 118.15 (2xC), 117.21(2xC), 107.45 (2xC), 75.10 
(2xC), 65.47, 65.46, 55.19, 55.18, 51.43 (2xC), 40.44, 40.40, 40.07, 40.01, 39.34 (2xC), 37.55, 37.42, 37.36, 37.26, 
35.25 (2xC), 32.76, 32.70, 31.06, 31.03, 31.02, 30.96, 27.95 (2xC), 24.79, 24.42, 24.00, 23.72, 22.70, 22.61, 21.10, 
21.01, 19.73, 19.66, 19.60, 19.57, 18.88 (2xC), 18.01 (2xC), 12.25 (2xC). HRMS (APCI+) m/z calcd. for 
C48H66NO2S [MH]+:720.4809, found: 720.4781 (3.9 ppm). ῦmax (thin film)/cm-1: 2943, 2866, 1711, 1605, 1490, 
1460, 1102, 742, 698. 
4-Phenyl-3-(propylthio)but-3-en-2-one 81 
yellow oil. E-isomer: 1H NMR (400 MHz, CDCl3) δ 7.34-7.21 (m, 2H), 6.85 (s, 1H), 2.66 
(app t, J = 7.3 Hz, 2H), 2.24 (s, 3H), 1.72–1.63 (m, 2H), 1.02 (t, J = 7.3 Hz, 3H);13C NMR 
for E-isomer (100 MHz, CDCl3) δ 202.8, 137.3, 135.3, 132.0, 128.6, 128.4, 128.2, 34.7, 29.9, 
22.5, 13.3; HRMS (ESI) m/z calcd. for C13H17OS [MH]+:  221.0994, found: 221.0995 (0.3 
ppm); ῦmax (thin film)/cm-1: 2962, 2927, 1694, 1354, 1172, 757, 699. Z-isomer: 1H NMR (400 
MHz, CDCl3) δ 7.86-7.83 (m, 2H), 7.64 (s, 1H), 7.43–7.34 (m, 3H), 2.67 (app t, J = 7.2 Hz, 
2H), 2.55 (s, 3H), 1.56–1.47 (m, 2H), 0.90 (t, J = 7.4 Hz, 3H); 13C NMR for Z-isomer (100 MHz, CDCl3) δ 198.6, 
141.6, 136.3, 134.7, 130.9, 129.5, 128.3, 35.9, 27.5, 23.2, 13.3; HRMS (ESI) m/z calcd. for C13H17OS [MH]+:  
221.0995, found: 221.0995 (0.3 ppm); ῦmax (thin film)/cm-1: 2963, 2929, 1677, 1204, 1219, 1181, 755, 691. 
(1,2-Diphenylvinyl)(propyl)sulfane 83 
 yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 7.2 Hz, 2H), 7.63 (d, J = 7.8 Hz, 2H), 
7.42-7.29 (m, 12H), 7.13–7.08 (m, 4H), 6.96 (d, J = 7.6 Hz, 2H), 6.83 (s, 1H, major), 6.17 (s, 
1H, minor), 2.54 (t, J = 7.2 Hz, 2H, minor), 2.42 (t, J = 7.2 Hz, 2H, major), 1.68–1.69 (m, 
2H, minor), 1.52–1.43 (m, 2H, major), 0.99 (t, J = 7.4 Hz, 3H, minor), 0.85 (t, J = 7.4 Hz, 
3H, major). 13C NMR (100 MHz, CDCl3) δ 141.2, 138.3, 138.1, 137.8, 137.1, 136.8, 131.9, 
129.6, 129.5, 128.8, 128.6, 128.3, 128.0, 127.9, 127.9(3), 127.8, 127.1, 126.6, 126.4, 34.8, 33.8, 23.2, 22.5, 13.4, 
13.2. HRMS (APCI) m/z calcd. for C17H19S [MH]+: 255.1187, found: 255.1202 (5.7 ppm).  ῦmax (thin film)/cm-1: 




7. ABBREVIATION LIST 




AC Absolute Configuration  
B3LYP Becke, 3-parameter, Lee–Yang–Parr 
BET Back electron transfer 
BH&H-LYP Becke-Half-and-Half, Lee–Yang–Parr 
br s Broad singlet 
calcd. Calculated  
CAM Coulomb-attenuating method 
CFL Compact Fluorescent Lamp 
cm Centimeter 
COSY COrrelated SpectroscopY 
CSP Chiral Stationary Phase 
d Doublet 





dd Double doublet 
ddd Doublet of doublets of doublets 
DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DEPT Distortionless Enhancement by Polarization Transfer 
DFT Density Functional Theory 
DMF N,N-dimetilformammide 
DMSO Dimethylsulfoxide 
dq Double quartet 
ECD Electronic Circular Dichroism 
EDA Electron Donor Acceptor 
EDG Electron Donating Group 
equiv. Equivalents 
ESI Electrospray Ionisation 
eV Elettronvolt 
EWG Electron Withdrawing Group 
GHD Glucose Dehydrogenase 
h Hour(s) 
HAT Hydrogen Atom Transfer 
HFIP 1,1,1,3,3,3-Hexafluoro-2-propanol 
HMQC Heteronuclear Multiple-Quantum Correlation 
HPLC High Performance Liquid Chromatography 
HRMS High-Resolution Mass Spectrometry 
Hz Herz 
hνCT Charge-Transfer Band 
ICD  Intramolecular Conjugate Displacement 
IR InfraRed 












mp Melting point 
MSD Mass Selective Detector 
n- Normal 
NADP+ Oxidized form of Nicotinamide Adenine Dinucleotide phosphate 
NADPH Reduced form of Nicotinamide Adenine Dinucleotide phosphate 
NBS N-Bromosuccinimide 
nm Nanometers 
NMR Nuclear Magnetic Resonance 
NOESY Nuclear Overhauser Effect Spectroscopy 
o- Ortho- 
ORSA Organic Reactions for Synthetic Applications 
ORTEP Oak Ridge Thermal-Ellipsoid Plot Program 
p- Para- 
PCM Polarizable Continuum Model 




qd Doublet of quartets 
QTOF Quadrupole Time of Flight 
r.t. Room temperature 
s Seconds 
s Singlet 
SET Single Electron Transfer 




td Triplet of doublets 
TD-DFT Time dependent - Density Functional Theory 
TFA Trifluoroacetic acid 
TFE 2,2,2-Trifluoroethanol 
THF Tetrahydrofuran 
TLC Thin Layer Chromatography 
TOF Time of Flight 




ῦmax Maximum frequencies 
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